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1.    Introduction 
 
1.1.    St. John’s wort extracts 
 
Preparations from the aerial parts of St. John's wort (Hypericum perforatum L.) are used for 
the treatment of mild to moderate depression in many countries (Müller, 2003). The extracts 
are an accepted alternative to synthetic antidepressants and behavioural therapy. Thus, they 
are used in a therapeutic area which well extends beyond the traditional field of herbal 
medicine. St. John's wort extracts exhibit an inhibitory effect on the neuronal reuptake not 
only of serotonin, noradrenaline, and dopamine but also of gamma-aminobutyric acid (GABA) 
and L-glutamate. No other antidepressant shows an equally broad inhibitory profile. 
 
Over the past years, a number of double-blind, randomized and controlled clinical studies 
were carried out which demonstrated the efficacy and good tolerability of St. John's wort 
extracts in mild to moderate depressive disorders (Müller, 2003). The therapeutic efficacy has 
only been questioned by a recent American study (Shelton et al., 2001). However, this clinical 
trial included patients with severe depression, an indication for which St. John’s wort extracts 
are not approved. Furthermore, a synthetic antidepressant used as a comparative drug also 
failed to be superior to placebo. So far, all clinical studies including the latter one confirmed 
the low frequency of adverse events caused by Hypericum preparations. However, a number 
of drug interactions have been found to occur with St. John's wort extracts, some of which are 
of clinical relevance (Müller, 2003).  
 
Preparations from St. John's wort are among the most prescribed medicines in Germany 
(Lohse et al., 2000; Schulz et al., 2001). The numbers of prescriptions have approximately 
tripled since 1993. In 1999, around 130 million daily doses were prescribed. As a result of the 
health reform in Germany, the costs for Hypericum preparations are generally no longer 
reimbursed by the statutory health insurance providers, even though their benefit and safety 
have been unequivocally demonstrated. The costs for St. John's wort preparations are 
significantly lower than those for synthetic antidepressant medications. In the USA, St. John's 
wort extracts are increasingly used as an over-the-counter remedy for the treatment of 
depression. Some American medical societies recently included St. John's wort as an 
antidepressant in their guidelines on the drug treatment of depressive disorders.  
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The recommended minimum dosage for St. John’s wort preparations is 500 mg per day of a 
5:1 extract from the flowering tops and leaves. The minimum time of treatment is 4-6 weeks. 
 
1.2.    Depression 
 
 
Depression is a common and potentially life-threatening (risk of suicide) disorder with an 
estimated life time prevalence of around 17% (Kessler et al., 1994). Its prevalence in Western 
industrialized nations is estimated to be approx. 3% in males and 7% in females (Depression 
Guideline Panel, 1993). Women experience depression about twice as often as men (Blelhar 
and Oren, 1995). Many hormonal factors may contribute to the increased rate of depression in 
women. The World Health Organization (WHO) estimates that the burden of depressive 
illness by the year 2020 will parallel morbidity and economic loss caused by heart disease 
(World Health Organization, 1998). Apart from the personal suffering of patients, depression 
is extremely expensive for health insurance systems, in terms of medication, medical 
consultation, days off work etc. 
 
The major biological cause of depression is the deficiency in neurotransmitters which regulate 
mood and emotion, such as serotonin and noradrenaline (norepinephrine) (Müller, 2003). 
Antidepressant medications treat depression by restoring the normal levels of these two 
neurotransmitters released into the synaptic gap. Importantly, these acute effects are followed 
within 1-2 weeks by adaptive changes at the level of the receptors, e.g. up-regulation of α1 
and 5-HT1 receptors and down-regulation of ß and 5-HT2 receptors in the frontal cortex. 
These adaptive changes in the density of the receptors correlate with the time course of the 
antidepressant effect in patients.  
 
The clinically used antidepressant drugs, e.g. the tricyclics imipramine and amitriptyline and 
the monoamine oxidase (MAO)-inhibitors phenelzine and tranylcypromine, were introduced 
more than forty years ago (Müller, 1997). Although powerful antidepressants, their 
therapeutically use was always accompanied by the burden of a high frequency of side effects. 
These problems led to the development of a number of second and third generation 
antidepressant drugs, such as reversible MAO-A inhibitors, specific serotonin reuptake 
inhibitors (SSRI), and specific serotonin and norepinephrine reuptake inhibitors. None of 
these newly developed antidepressants have conclusively shown to be superior to tricyclics in 
terms of antidepressive efficacy, but most of these newer compounds are better tolerated and 
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safer in overdose. Accordingly, in many western countries, the second generation compounds 
such as the SSRIs account for most of the antidepressant drug prescriptions. 
 
1.3.    Hypericum perforatum L. 
 
 
Saint John’s wort, also called common or perforate St. John’s wort (Fig. 1-1), belongs to the 
family Clusiaceae (formerly Hypericaceae or Guttiferae). The species name “perforatum” is 
Latin for “perforated”. The leaves of H. perforatum, when held to the light, reveal translucent 
dots, giving the impression of perforated leaves. The dots are large spherical glands spanning 
the whole leaf from the upper to the lower epidermis (Weiss, 1988). They contain essential oil 
comprising caryophyllene, pinenes, limonene, and myrcene as major components.  
Besides the colorless glands, leaves contain dark red to black glands which accumulate 
hypericins. Especially the petals of the bright yellow-orange flowers are peppered with the 
black dots. When petals are rubbed between the fingers, a red sap is squeezed out and stains 
the fingers red. The stem of  H. perforatum is unusual in that it has two raised lines making it 
appear pressed flat. Most plants have round or four-square stems (Weiss and Fintelmann, 
2000).  
 
St. John's wort is native to Europe and occurs throughout this continent, except the extreme 
North (Erdelmeier, 1998). In Asia, Africa, North and South America and Australia, it has 
been naturalized in waste places and along roadsides. It is one of those European native plants 
that have followed European settlers wherever they travelled in the world. The plant was 
introduced by early settlers to North America. In 1793, the first recorded specimen, grown 
without cultivation, was collected in Pennsylvania (Hahn, 1992). 
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                                     Fig. 1-1: Hypericum perforatum L. 
 
 
1.3.1    Constituents 
 
 
 St. John's wort is one of the best studied medicinal plants. It contains a complex mixture of 
secondary metabolites (Kurth and Spreemann, 1998). The main constituents are shown in Tab. 
1-1 (Butterweck and Nahrstedt, 2003). The pharmacological activity of Hypericum 
preparations is attributed to hyperforins, hypericins and flavonoids (Simmen et al., 2001; 
Butterweck et al., 2001). The effectiveness of formulations to relieve depression depends on 
their hyperforin content (Laakmann et al., 1998).  
 
Hypericins and flavonoids were found to have an effect in the Porsolt (forced swimming) test 
(Butterweck, 2003). These observations, however, were questioned by other authors (Müller, 
2003). The biological evaluation of hypericins is hampered by their poor water solubility 
which, however, can be increased in the presence of procyanidins (Butterweck, 2003). 
Hypericins also show anti-inflammatory activity by inhibiting release of leukotrienes 
(Panossian et al., 1996) and prevent replication of encapsulated viruses in animal models 
(Meruelo et al., 1989). 
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Among the flavonoids are rutin, hyperoside, isoquercitrin, quercitrin and quercetin. The 
glucoside, galactoside and glucuronide of quercetin were active compounds in the Porsolt test, 
which was attributed to differences in the bioavailability of the glycosides (Butterweck, 2003). 
The aglycone quercetin was inactive in the forced swimming test. Besides their antidepressant 
properties, flavonoids were found to exhibit antioxidant activity (Sloley et al., 2000). This 
property was proposed to increase the overall extract efficacy by preventing oxidative 
degradation of other phytochemicals in Hypericum preparations.  
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Tab. 1-1: Major constituents of St. John's wort   
 
Group of 
compounds 
Chemical structure Individual names Approx. 
content in  
plant extracts 
[%] 
Flavonoids  
O
O
O
O
O
H
H
R
OH
OH
 
 R = H                         quercetin 
 R = α-L-rhamnosyl    quercitrine 
 R = β-D-glucosyl       isoquercitrin 
 R = β-D-galactosyl    hyperoside 
 R = β-D-rutinosyl      rutin 
 R = α-D-glucuronyl    miquelianin 
0.2 - 0.6 
0.2 - 0.4 
0.5 - 0.8 
2 -  4 
2 - 3 
0.4 - 0.5 
Anthracene  
derivatives 
 
OOH OH
ROH
OH
OH O
CH3
OH
 
 
 R = CH3              hypericin 
 R = CH2OH        pseudohypericin 
  
0.08 - 0.2 
0.15 - 0.4 
Prenylated 
phloroglucin-
ols 
O
O
OHO
R
 
 
 R = H                   hyperforin 
 R = CH3               adhyperforin 
 
 
0.9  -  5 
Biflavones  
O
OOH
OH O
OH OH
OH
O
OH
 
 
 
 I3', II8-biapigenin (amentoflavon) 
 I3, II8-biapigenin  
 
 
 
0.01- 0.05 
0.2 -  0.6 
Phenylpro-
panes 
(caffeic acid 
derivatives) 
 
OH
OH
OHO
OH
O
OH
OH
 
 
e.g. chlorogenic acid 
 
 < 1 
Xanthones 
O
OH
OH
O
OH
OH
 
 
1,3,6,7-tetrahydroxyxanthone 
 
 < 0.0004 
Proantho-
cyanidins 
 
O
OOH
OH
OH
OH
OH
OH
OH
OH
OH
OH
 
 
e.g. procyanidines 
 
Traces 
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1.4.    Hyperforin 
 
 
Hyperforin [C35H52O4] (Fig. 1-2) is the major acylphloroglucinol in H. perforatum. Its content 
increases up to 5% of dry weight in flowers and leaves (Erdelmeier et al., 1998). The 
concentration of hyperforin changes during flower ontogenesis (Tekel'ovà et al., 2000). The 
content increased from 2.5% in the first developmental stages of buds to 6.6% in flowers just 
opened. In fruits, the amount even reached 8.1%.  
 
Hyperforin was found in 1971 as the antibacterial principle of St. John's wort by Russian 
researchers (Gurevich et al., 1971). Hyperforin was shown to be active against gram-positive 
bacteria such as Staphylococcus aureus. There were earlier reports on the antibacterial 
properties of lipophilic extracts from H. perforatum (Neuwald and Hagenström, 1954). In the 
United States, a patent was granted in 1951 for the use of H. perforatum extracts as food 
preservative (Jensen, 1951). 
 
                                  
O
O
OHO
R
                                                             
                             Hyperforin   R = H                                                                       
                                                   Adhyperforin R = CH3 
                                 
                               Fig. 1-2: Chemical structure of hyperforins 
  
Hyperforin is poorly stable when extracted from the herb and exposed to light and air 
(Erdelmeier, 1998; Bilia et al., 2001). Its liability to oxidation complicates the preparation of 
pharmaceutical and nutritional formulations of H. perforatum extracts (Guilhermano et al., 
2004). The pharmacological activities may be rapidly lost during storage.  
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 1.4.1    Pharmacology 
 
Hyperforin inhibits the reuptake of serotonin, noradrenaline, dopamine, GABA (gamma-
aminobutyric acid) and L-glutamate to similar extents, which is in clear contrast to the 
properties of all other known antidepressants. The combination of these effects gives it 
antidepressive and sedative properties (Teufel and Gleitz, 1997). The research has challenged 
this belief, focusing on hyperforin (Calapai et al., 1999). It is not only the broad-spectrum 
activity but also the underlying mode of action that is unique to hyperforin. The compound 
does not directly interact with the transmitter transporters but elevates the intracellular sodium 
concentration, thereby inhibiting the gradient-driven neurotransmitter reuptake (Singer et al., 
1999). This is a novel mechanism of action which explains the broad-band reuptake inhibitory 
activity. Synthetic antidepressants are competitive inhibitors of one or maximally two 
transporters at the transmitter binding sites. Among all individual constituents of St. John`s 
wort, hyperforin is the only neurotransmitter reuptake inhibitor.  
   
Besides uptake inhibition, hyperforin has the ability to inhibit in vivo the growth of human 
and rat  tumour cell lines by induction of apoptosis (Schempp et al., 2002). In addition, it was 
shown to display antibacterial properties, explaining the traditional use of St. John’s wort 
extracts for the local treatment of infected wounds (Hubner, 2003). 
 
Hyperforin is also a potent ligand for the pregnane X receptor which regulates the expression 
of CYP 3A4 which in turn is involved in the oxidative metabolism of >50 % of all drugs 
(Moore et al., 2000). This can lead in the case of co-medication to a reduction of the plasma 
levels of other medications. Relevant interactions occur with drugs such as cyclosporin and 
protease inhibitors, resulting in a clear contraindication for St. John`s wort.   
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1.5.     Prenyltransferases 
 
 
A biosynthetic pathway of hyperforin was proposed on the basis of retrobiosynthetic analyses 
(Adam et al., 2002). The structure of hyperforin is derived from an acylphloroglucinol 
skeleton which is expanded into a bicyclo[2,2,1]nonaendionol, substituted with several 
lipophilic isoprenoid chains. The enzymes involved in prenylation and utilization of 
isopentenyl diphosphate (IPP) and its allylic isomer dimethylallyl diphosphate (DMAPP) are 
deemed prenyltransferases in accordance with the terminology proposed by Holloway and 
Popjàk (1967). Prenyltransferases are classified as follows: 
 
1. Prenyl-prenyltransferases (chain-elongating prenyltransferases): Enzymes that (a) transfer 
IPP units to allylic diphosphates such as DMAPP, GPP and FPP in a head-to-tail 
fashion or (b) condense C15 or C20 prenylpyrophosphates in a tail-to-tail fashion. 
 
2. Prenyl-aryltransferases (aromatic prenyltransferases): Enzymes that transfer (a) a mono- 
             prenyl group or (b) a polyprenyl group to an aryl moiety. 
 
Prenyltransferases generally mediate electrophilic reaction mechanisms involving 
carbocationic intermediates, a feature of terpenoid biochemistry (Croteau et al. 2000). The 
resonance-stabilized carbocation, generated by the pyrophosphate leaving group, can react 
with an extender substrate such as IPP. 
Prenylation of aromatic substrates is involved in the biosynthesis of diverse molecules that 
play important roles in bacteria to mammals, e.g. electron transport via ubiquinone and 
plastoquinone (Grunler et al., 1994). In higher plants, prenylation reactions highly contribute 
to the diversification of aromatic secondary metabolites, with regard to both their chemical 
structures and biological activities. For instance, some prenylated flavonoids act as 
phytoalexins that are involved in plant defence mechanisms (Tahara and Ibrahim, 1995; 
Morrandi, 1996). Furthermore, they were reported to be potential natural medicines 
(Henderson et al., 2000; Miranda et al., 2000) 
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1.6.    Hypericum calycinum L. 
 
Recently, the formation of hyperforin and its homologue adhyperforin has been observed in 
cell cultures of Hypericum calycinum which are thus a valuable in vitro system for studying  
hyperforin biosynthesis (Klingauf et al., 2005). 
 
                                                                                                                                                                                                                                      
 
                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                    
                                            Fig.1-3: Hypericum calycinum L. 
 
 
 
So far, hyperforins have not been detected in differentiated plants of H. calycinum, although 
several dearomatized polyprenylated acylphloroglucinols have been isolated from this species. 
These compounds accumulate in those parts of petals which are exposed to the outside in the 
unopened bud. This is the first time that constituents other than flavonoids were found to 
serve as floral UV pigments. Interestingly, the polyprenylated compounds also accumulate to 
a high extent in the anthers and ovarian wall and provide protection against herbivores. Thus, 
they fulfill both attractive and defensive functions in H. calycinum flowers (Decosterd et al., 
1998; Gronquist et al., 2001).  
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1.7.    Research strategies and objectives 
 
 
The biosynthesis of hyperforins starts with a polyketide synthase reaction giving 
acylphloroglucinols. This aromatic intermediate undergoes a series of prenylation reactions, 
accompanied by an intramolecular cyclization to yield the bicyclic molecule. The goal of the 
present work was to study at the enzyme and gene levels the prenyltransferases participating 
in hyperforin biosynthesis (Fig. 1-4). The experiments were carried out with cell cultures of H. 
calycinum. The focus was on the enzyme that catalyzes the first prenylation step. 
 
HO OH
OH O
phlorisobutyrophenone
OOH
HO OH O
O
HO
O
DMAPP
dimethylallyl-
phlorisobutyrophenone
hyperforin
 
Fig. 1-4: The first prenylation step in hyperforin biosynthesis 
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2.      Materials 
 
 
2.1.    Chemicals, nutrient media, solutions, buffers, equipment 
 
 
2.1.1    Chemicals 
 
 
Commonly used chemicals and gases were purchased in standard grade from the  
following companies: 
 
Aldrich                               Fluka                            Roth 
 Applichem                         Merck                           Serva 
   Bio-Rad                             Riedel-deHaën              Sigma 
Aqueous solutions were prepared with milli-Q water that was purified by using the Milli-Q  
Water Purification System (Millipore). 
 
 Special chemicals 
 
 
A. Enzyme assay 
 
2,4,6-Trihydroxyacetophenone                                  Acros Organics 
Phloroglucinol                                                            Fluka 
Phlorbenzophenone                                                     ICN 
Naringenin                                                                 Sigma 
DTT (1,4-Dithiothreitol)                                            AppliChem 
DTE (1,4-Dithioerythritol)                                         Roth 
Isopentenyl diphosphate                                             Sigma 
Geranyl diphosphate                                                   Sigma 
Farnesyl diphosphate                                                  Sigma 
Geranylgeranyl diphosphate                                       Sigma 
DMSO                                                                         Fluka 
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B. Enzyme purification 
 
Ammonium sulphate                                                   Roth 
Protein Molecular Weight Ladder                              Fermentas 
PD10-Sepharose G-25                                                Amersham Pharmacia Biotech 
 
C. Gel Electrophoresis 
Molecular weight marker kit                                       Sigma 
Acrylamide/bis-acrylamide                                         Bio-Rad 
Ammonium persulfate (APS)                                      Bio-Rad 
Bromphenonl Blue                                                       Aldrich 
Coomassie Brilliant blue G250                                    Merck 
Sodium dodecyl sulphate (SDS)                                  Roth 
TEMED (N, N, N´, N´-Tetramethylethylenediamine)   Bio-Rad                        
Iodoacetamide                                                             Acros Organics 
Ampholyte                                                                  Bio-Rad 
ReadyStripTM IPG Strip                                              Bio-Rad 
Agarose, NEE Ultra Quality                                       Roth 
Blotting filter paper                                                    Schleicher & Schuell 
Formaldehyde, 37%                                                    Roth 
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2.1.2    Nutrient media for plant tissue cultures 
 
Media were prepared as described below (Tab. 3-1). Aliquots of 50 ml were filled into 300 ml 
Erlenmeyer flasks, sealed with aluminium caps and sterilized by autoclaving at 120°C for 20 
minutes.  
Tab. 3-1: Stock solutions and preparation of media 
 
 
Medium  Composition  Preparation and use  
 
BDS-Liquid 
medium 
(modified  B5 
medium; 
Gamborg et al., 
1968; 
Dunstan and 
Short, 1977) 
I 
CaCl2·2H2O  150 mg/l 
KNO3                                           2530 mg/l 
NH4NO3  320 mg/l 
NH4H2PO4  230 mg/l 
(NH4)2SO4  134 mg/l 
MgSO4·7H2O  247 mg/l 
MnSO4·4H2O 13.2 mg/l 
ZnSO4·7H2O   2.0 mg/l 
 
II 
CuSO4·5H2O                               0.039 mg/l 
KI 0.75 mg/l 
CoCl2·6H2O                                0.025 mg/l 
Na2MoO4·2H2O                            0.25 mg/l 
H3BO3   3.0 mg/l 
NaH2PO4·2H2O  172 mg/l 
 
III 
FeSO4 27.85 mg/l 
TitriplexIII (Na2EDTA· 2H2O) 37.25 mg/l 
 
 
IV 
Nicotinic acid   1.0 mg/l 
Thiamine hydrochloride 10.0 mg/l 
Pyridoxal hydrochloride   1.0 mg/l 
myo-Inositol                               100.0 mg/l 
 
V 
Kinetin (6-Furfurylaminopurine) 100 mg/l 
Dicamba  7.5 mg/l 
(3,6-Dichloro-2-methoxybenzoic acid) 
 
VI 
Sucrose       30 g/l 
Mix with 800 ml  
distilled water, add 
and dissolve 
saccharose, adjust the 
volume to one liter 
with water and the 
pH to 5.5. Autoclave 
 
Nutrient medium  for  
cell suspension 
cultures 
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LS-Liquid 
medium 
(Linsmeier 
and Skoog, 
1965) 
 
I   
KNO3  1900 mg/l 
NH4NO3 1650 mg/l 
CaCl2 ·2H2O   440 mg/l 
MgSO4·7H2O   370 mg/l 
KH2PO4   170 mg/l 
II   
MnSO4·H2O 16.90 mg/l 
ZnSO4·7H2O                                10.60 mg/l 
KI   0.83 mg/l 
H3BO3    6.20 mg/l 
Na2MoO4·2H2O    0.25 mg/l 
FeSO4·7H2O 27.80 mg/l 
CuSO4·5H2O 0.025 mg/l 
CoCl2·6H2O 0.025 mg/l 
III 
Titriplex III 
(Na2 EDTA · 2H2O) 41.30 mg/l 
IV   
myo–Inositol 100.0 mg/l 
Thiamine hydrochloride     0.4 mg/l 
V   
2,4-Dichlorophenoxy- 
acetic acid  0.22  mg/l 
1-Naphtylacetic acid 0.186 mg/l 
VI   
Sucrose                                         30  g/l 
 
Mix with 800 ml  
distilled water, add 
and dissolve 
saccharose, adjust the 
volume to one liter 
with water and the 
pH to 6-6.3 with 
concentrated NaOH 
solution. Autoclave 
 
Nutrient medium  for 
cell suspension 
cultures. 
 
 
LS-Solid 
medium 
See LS-Liquid medium, but add 8.0 g/l SELECT 
agar and heat the medium to nearly 80 °C 
 
Nutrient medium  for  
callus  cultures   
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2.1.3    Solutions, buffers for biochemical analysis 
 
Tab. 3-2: Buffers for extraction and enzyme incubation 
Name composition Preparation   and   
storage 
Extraction buffer 
0.1 M potassium 
 phosphate pH 6.5  + 0.1 
mM DTT 
Potassium dihydrogen phosphate   1.36 g 
DTT        15.4 mg 
Water                                          ad 100 ml 
pH adjusted by  
KOH, stored at 4°C  
DTT is added freshly 
Incubation buffer 
0.1 M Tris-HCl buffer  
pH 7.5 
Tris                                      1.21 g 
Water                                          ad 100 ml 
pH adjusted by 
concentrated HCl,  
stored at 4°C   
 
 
Tab. 3-3: Solution for regeneration of PD10- columns (Amersham Biosciences) 
 
 
Tab. 3-4: Solution for protein estimation 
 
 
 
 
 
 
 
 
 
NaOH Cleaning agent NaOH  0.16 M Wash the column 
with five column 
volumes of 0.16 M 
NaOH and then five 
column volumes of 
distilled water 
Bradford-dye solution 
 
Coomassie®-Brilliant               100 mg 
    blue G-250      
Ethanol 96 %                              50 ml 
Orthophosphoric acid                100 ml 
Water                                  ad 1000 ml 
Dissolve Coomassie® 
-Brilliant blue G-250 
in ethanol, add 
orthophosphoric acid 
and complete the 
volume with water. 
The solution should be 
stored in a refrigerator 
and filtered before use    
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2.1.4    Buffers for protein purification 
 
Tab. 3-5: Buffers for DEAE and Mono-Q anion exchange columns  
 
  
Tab. 3-6: Buffers for the HAP (CHT5-I) column   
 
 
Tab. 3-7: Buffers for HIC (Phenyl sepharose high performance column)  
 
 
Tab. 3-8: Buffer for Gel Filtration (HiPrep16/60 Sephacryl S-200 High Resolution 
column)  
 
 
 
Starting Buffer   pH 7.5 20 mM Tris   0.242 g 
1 mM DTT    150 µg 
Water                      ad 100 ml 
Filter, degas and 
store at 4°C, pH 
adjusted by 
concentrated HCl       
Elution Buffer   pH 7.5 20 mM Tris            0.242 g 
0.5 M KCl   3.72 g 
1 mM DTT   150 µg 
Water                     ad 100 ml 
 Filter, degas and 
store at 4°C, pH 
adjusted by 
concentrated HCl              
Starting Buffer   pH 7.5 10 mM  KH2PO4             0.136 g 
1 mM DTT    150 µg 
Water                      ad 100 ml 
  Filter, degas and 
store at 4°C    
Elution Buffer   pH 7.5 500 mM KH2PO4              6.804 g 
1 mM DTT    150 µg 
Water                      ad 100 ml 
  Filter, degas and 
store at 4°C    
Starting Buffer   pH 7.5 50 mM  KH2PO4    0.68 g 
1 M (NH4)2SO4                                13.21 g 
1 mM DTT   150 µg 
Water                      ad 100 ml 
Filter, degas and 
store at 4°C  
Elution Buffer   pH 7.5 50  mM KH2PO4    0.68 g 
 1 mM DTT   150 µg 
Water                     ad 100 ml 
Filter, degas and 
store at 4°C     
Starting and elution Buffer              
 
              pH 7.5 
 50 mM Tris                             6.057g 
100 mM KCl               7.456 g 
 1 mM DTT     1.5 mg 
Water                     ad 1000 ml 
Filter, degas and  
store at 4°C     
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2.1.5    Buffers and solutions for gel electrophoresis (SDS-PAGE): 
Tab. 3-9: Buffers and solutions for gel electrophoresis  
Stacking gel   Distilled water   3.4  ml 
1 M Tris-HCl (pH 6.8) 0.63 ml 
Acrylamide/Bis 30 % 0.83 ml 
10 % (w/v) SDS 0.05 ml 
10 % (w/v) APS 0.05 ml 
TEMED      5 µl 
 
Running   gel (12 %)  Distilled water   3.3 ml 
1.5 M Tris-HCl (pH 8.8)   2.5 ml 
Acrylamide/Bis 30 %   4.0 ml 
10 % (w/v) SDS   0.1 ml 
10 % (w/v) APS   0.1 ml 
TEMED      4 µl 
 
2x Protein Loading 
Buffer 
 Distilled water   2.7 ml 
0.5 M Tris-HCl (pH 6.8)  1.0 ml 
Glycerine    2.0 ml 
10 % (w/v) SDS   3.3 ml 
β-Mercaptoethanol   0.5 ml 
0.5 % (w/v)Bromphenol blue 0.5 ml  
Stored at 4 °C   
10x SDS-Electrode 
Buffer 
 
Tris base     15 g 
Glycin      72 g 
Na-SDS       5 g 
Water                    ad  500 ml 
Stored at  4 °C, 
before use 
 1:10 dilution 
Staining Solution Coomassie-blue R 250            25  ml  
Methanol              100 ml 
Acetic acid    20  ml 
Water                    ad  200 ml 
 
Coomassie-blue     Coomassie-blue R 250     0,5 g 
 Water       50 ml 
Dissolve the dye  in       
water and filtrate   
 
Destaining Solution 
     
Methanol      30 ml 
Acetic acid      20 ml  
Distilled water        ad  200 ml 
  
 Silver Staining  
Fixing solution 
     
30% ethanol                            150 ml 
10% acetic acid                        50  ml 
Distilled water       ad  500  ml   
 Store at room 
temperature 
  
Sensitizing solution 
     
30 % ethanol     150 ml 
0.5 M sodium acetate    20.5 g 
0.2 % Na2S2O3         1 g 
Distilled water         ad 500 ml 
  Store at room 
temperature 
 
Silver solution   
     
0.2 %  silver nitrate                 0.6   g 
0.01 % formaldehyde                30 µl 
Distilled water                    ad 300 ml 
  Prepare freshly 
    
Developing solution 
             
6 % Na2CO3                              18   g 
0.02 % formaldehyde                60  µl 
Distilled water         ad 300 ml 
   Prepare freshly  
     
 Stop solution 
1.5 %  Na2 EDTA                      4.5 g 
Distilled water         ad 300 ml 
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2.1.6    Buffers for First-Dimension Isoelectric Focusing (IEF): 
 
 
 
Tab. 3-10: Buffers for First-Dimension Isoelectric Focusing  
 
 
 
For second dimension SDS-PAGE (always fresh preparation): 
 
Addition of DTT: add 300 µl of a 1 M DTT solution to 20 ml SDS-equilibration buffer (4 
strips) to give a Final concentration of 15 mM.  
 
Addition of iodoacetamide: add 0.56 g to 20 ml SDS-equilibration buffer (4 strips) to give a 
final concentration of 0.15 M.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rehydration buffer a 7 M Urea    4.2 g  
2 M Thiouea    1.5 g 
4 % CHAPS    0.4 g 
50 mM DTT                          0.077 g 
Distilled water                          10 ml 
Shake  for 20 min, 
store in 1 ml aliquots 
at -80°C 
 Rehydration buffer b Rehydration buffer a   2.5 ml 
Ampholyte  125 µl 
Triton X-100                           125 µl 
 Bromophenol Blue               Trace  
(add with pipette tip)           
Store in 1 ml 
aliquots at -80°C 
SDS-Equilibration buffer 1.5 M Tris-HCL (pH 8.8)       10 ml  
Urea                                      72.07 g  
SDS      4 g 
Glycerol  69 ml  
 Bromophenol Blue                 Trace 
Distilled water                  ad 200 ml 
Store in 50 ml 
aliquots at -20°C 
 
  
 Materials and Methods                                                                                                             20                        
2.1.7    Equipment 
 
Balances  Large and small scale              Sartorius 
Water bath  Typ 3041    Köttermann 
   Exatherm U3    Julabo 
Heater block  Dri-Block DB 3D   Techne 
Incubator  HT     Infors 
Centrifuge  Universal 32R    Hettich 
   Biofuge 13    Heraeus Sepatech 
HPLC   1525 Binary HPLC Pump  Waters 
   2487 Dual λ Absorbance Detector Waters 
   Breeze GBC Software  Waters 
FPLC   Biologic-System   Bio Rad 
   Controller    Bio Rad 
   Fraction collector 2128  Bio Rad 
Photometer  Ultraspec 1000   Pharmacia Biotech 
Power supply            Standard Power Pack P25  Biometra 
   Power Pack 300   Bio Rad 
Electrophoresis Protein-Chamber    Biometra; Bio Rad 
Vacuum concentrator Genelac SF 50   Biometra 
 pH-Meter  Digital pH Meter 325   WTW (Wissenschaftlich- 
        Technische-Werkstätten) 
Autoclave               Vapoklav    Sterilco 
Clean bench  LaminAir HLB 2472   Heraeus 
Freeze dryer      Alpha     Christ 
Water distillation       Milli-Q Reagent Water  Millipore 
      Unit 
  
Magnetic rotator         Vibrax-VXR                                     IKA–Labortechnik (Janke & 
                                     VF2                                                   Kunkel), Staufen 
                                     Combimag Ret 
 
Multiphor™              II Electrophoresis unit                        Pharmacia 
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2.2.    Plant material    
 
2.2.1    Cultivation of callus and cell suspension cultures 
  
Callus tissue was grown on solid LS medium (Fig. 2-1). An aliquot was transferred onto new 
medium every three weeks. 
 
            
 
             Fig. 2-1: Callus culture of H. calycinum on solid LS medium 
 
Callus tissue was suspended in liquid LS medium (Fig. 2-2). The resulting cell suspension 
cultures were propagated in 200 ml Erlenmeyer flasks at 100 rpm and 25°C in the dark. For 
growth curves and enzyme assays, 3 g cells were inoculated into 50 ml liquid BDS medium at 
7-day intervals (Fig. 2-3). 
 
 
2.2.2    Cell harvest    
 
Cell cultures were collected by suction filtration through filter paper in a Büchner funnel. The 
fresh weight was determined. 
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Fig. 2-2: Cell suspension culture of                           Fig. 2-3: Cell suspension culture of 
                 H. calycinum in LS medium                                    H. calycinum in BDS medium 
                   
 
 
3.    Methods 
 
3.1.    Syntheses and analytical work 
 
3.1.1    Synthesis of dimethylallyl diphosphate   
 
Dimethylallyl diphosphate was prepared by the method of Cramer and Böhm (1959), 
modified by Popják et al. (1966). Trichloroacetonitrile (36 mmol) and di-triethylammonium 
phosphate (14.4 mmol) were added slowly through a dropping funnel to 3,3-dimethylallyl 
alcohol (6 mmol) at  room temperature over a period of 3-4 hours, the mixture being stirred 
continuously. After standing for another 2 hours at room temperature, the reaction mixture 
was diluted with 100 ml of ether, transferred to a separating funnel and extracted three times 
with 25-30 ml of 0.1 N aq. ammonia. The aqueous extracts were combined and concentrated 
to a few millilitres on a rotary evaporator (bath temperature about 50°C). 
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3.1.1.1     Purification of synthetic dimethylallyl diphosphate 
 
The aqueous concentrate obtained above was applied to a column of silica gel (0.063-0.200 
mm, VWR international company; 60 x 1.3 cm) equilibrated with n-propanol-conc. ammonia 
(sp. gr. 0.88)-water (6:3:1, by volume). The same solvent system was used for elution. 3 ml 
fractions were collected. Fractions containing dimethylallyl diphosphate (No. 35-44, eluted 
after the monophosphate) were combined and concentrated to few millilitres (2-4 ml), made 
alkaline with a drop of ammonia and freeze dried. 
 
3.1.1.2    Thin layer chromatography (TLC) 
 
For detection of dimethylallyl diphosphate, samples, e.g. aliquots of the above fractions,  
were spotted onto a TLC plate (silica gel 60 F254, 20 x 20 cm, thickness 0.2 mm; Merck, 
Darmstadt). The solvent was n-propanol-conc. ammonia (sp. gr. 0.88)-water (6:3:1, by 
volume). After drying and spraying with ferric chloride-sulfosalicylic acid, phosphate-
containing compounds appeared as white spots on a pink background.  
 
3.1.1.3    NMR-analysis 
 
NMR spectra were obtained on a Bruker Advance 400 spectrometer at operation frequencies  
of 400 MHz (1H) and 101 MHz (13C), respectively.  
The solvent was CDCl3 and the chemical shifts were referenced to TMS (± H D 0.00) and to  
CDCl3  (CD 77.0). The spectrometer software used was XWinNMR version 3.1. 
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3.1.2    Synthesis of dimethylallylphlorisobutyrophenone  
 
The reaction was conducted according to Li Xiao et al. (1998). 800 mg 2-methyl-1-(2,4,6-
trihydroxyphenyl)-propan-1-one (4.1 mmol) was dissolved in 10 ml aqueous KOH (4.9 
mmol) and cooled to 0°C. 910 mg prenyl bromide (6.1 mmol) was added dropwise over 5 min 
at 0°C. After stirring for 1 h at room temperature, the reaction mixture was poured into 10 ml 
of ice-water, acidified with HCl (10 %) to pH 2 and extracted with ethyl acetate (3 x 10 ml). 
The combined organic phases were dried over Na2SO4 and concentrated under reduced 
pressure. 
 
3.1.2.1    Purification of synthetic dimethylallylphlorisobutyrophenone 
 
Due to instability in silica gel, the reference compound was chromatographed on Sephadex 
LH-20 (2.5 x 40 cm; Amersham Biosciences, Freiburg, Germany) using methanol (70 %) as 
solvent. Further purification was achieved by semi-preparative HPLC (0.8 x 25 cm; Eurosorb-
100 C18) using water and methanol as solvents. The flow rate was 3 ml/min and the following 
gradient was used. 
 
Tab. 3-11: HPLC program  
Gradient Time [min] Methanol  [%] Water [%] Wavelength [nm] 
   0 
2 
32 
37 
40 
42 
47 
  
50 
50 
80 
100 
100 
50 
50 
  
50 
50 
20 
0 
0 
50 
50 
  
291 
 
 
 
3.1.2.2    Thin layer chromatography (TLC)  
 
TLC was carried out on silica gel (3.1.1.2.). The solvent was diethyl ether : pentane (60:40). 
After drying, detection of dimethylallylphlorisobutyrophenone was under UV-Light. 
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3.1.2.3    High performance liquid chromatography (HPLC)  
 
3.1.2.3.1   Instrumental 
 
Pumps: Waters 1525 Binary HPLC Pump 
Detector: Waters 2487 Dual Absorbance 
Software: Waters Breeze GPC 
Column: C18 100-5 (25 x 0.4 cm; Macherey-Nagel, Düren, Germany) 
 
HPLC photo diode array detection 
Injector: Waters712 auto sampler 
Detector: Waters 991 photo diode array 
Pumps: Waters 
Controller: Waters 600E system 
Column: C18 100-5 (25 x 0.4 cm; Macherey-Nagel, Düren, Germany) 
 
3.1.2.3.2     Mobile phases 
 
Enzymatic products were analyzed by HPLC using linear gradients of methanol (solvent A) 
and bidistilled water (solvent B), both containing 1% (v/v) ortho-phosphoric acid (Tab. 3-12) 
 
Tab. 3-12: HPLC programs  
 
 
Gradient Time [min] Methanol  [%] Water [%] Wave 
length [nm] 
1 0 
2 
32 
37 
40 
42 
47 
 
50 
50 
80 
100 
100 
50 
50 
 
50 
50 
20 
0 
0 
50 
50 
291 
2 0 
5 
20 
25 
27 
3 
50 
50 
100 
100 
50 
50 
50 
50 
0 
0 
50 
50 
291 
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3.1.2.4    GC-MS – Analysis 
 
3.1.2.4.1    Instrumental 
 
Precolumn: 2 m x 0.32 mm fused silica (Phenomenex) 
Analytical column: 30 m x 0.32 mm ZB1 (Phenomenex) 
Injection volume: 1µl 
Injector and transfer line: 280 °C 
Temperature program: 100 °C (3 min) - 300 °C (5 min) at 10 °C min-1  
Split ratio: 1:20  
Gas flow: 1.6 ml/min He 
 
The capillary column was directly coupled to a triple quadruple mass spectrometer  
Finnigan TSQ 700. The retention index (RI) was calculated by a set of hydrocarbons (even  
numbered C12 to C28) by linear interpolation. 
 
 
 
3.1.2.4.2    Sample preparation 
 
The synthetic reference compounds (dimethylallylphlorisobutyrophenone and dimethylallyl- 
phloracetophenone) and enzymatic products were first acetylated. The products were 
dissolved in 10µl dry pyridine and 10 µl acetic acid anhydride. After 1 h at room temperature, 
the reaction was quenched by addition of 100 µl methanol, and an aliquot was analyzed by 
GC-MS.  
 
 
 
3.1.3    Synthesis of dimethylallylphloracetophenone   
 
 
The reaction was conducted according to Li Xiao et al. (1998). 2,4,6-Trihydroxyaceto- 
phenone (7 mmol) was dissolved in 5.3 ml aq. KOH (10%) and cooled to 0 °C. Prenyl 
bromide (10.5 mmol) was added dropwise over 5 min. After stirring for 1 h at room 
temperature, the reaction mixture was poured into 10 ml of ice-water, acidified with HCl 
(10 %) to pH 2 and extracted with ethyl acetate (3 x 10 ml). The combined organic phases 
were dried over Na2SO4, and concentrated under reduced pressure. 
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3.1.3.1    Purification of synthetic dimethylallylphloracetophenone 
 
 
The concentrate obtained in the previous step was chromatographed on silica gel (0.063- 
0.200 mm, VWR international company; 60 x 1.3 cm) using different solvent mixtures (A:  
ethyl acetate : dichloromethane : acetic acid (10.5 : 80.5 : one drop); B: diethyl ether : pentane  
(60 : 40)). The fractions containing the desired compound were combined and concentrated    
on a rotary evaporator.   
 
  
 
3.1.3.2    Thin layer chromatography (TLC)
 
 
 
TLC was carried out on silica gel (3.1.1.2) using the above solvent (3.1.3.1). Detection   
was under UV-light. 
 
 
 
3.2.    Enzyme extraction and incubation 
 
 
 
3.2.1    Preparation of cell-free extracts          
 
 
Cultured cells (5g) were mixed with 0.5 g Polyclar AT (to adsorb phenolics) and a spatula  
of seasand. The mixture was homogenised for 15 min in 5 ml of 0.1 M KH2PO4 buffer, pH  
6.5 containing 10 mM DTT (to protect SH groups). After centrifugation at 13000 rpm at   
4 °C for 15 min, the supernatant was passed through a PD10 column and the high-molecular  
weight fraction was eluted with 3.5 ml of 0.1 M Tris-HCl buffer (pH 7.5). 
 
3.2.2    Protein determination 
 
 
Protein concentrations were measured by the method of Bradford (1976) using bovine 
serum albumin (BSA) as standard. To obtain a calibration curve, aliquots containing 1 µg- 
10 µg BSA was mixed with 900 µl freshly prepared Bradford dye solution. The volume was 
made up to 1 ml with water and the contents in each cuvett were mixed carefully. After 5 min 
the absorbance of the samples at 595 nm was measured using a blank of 900 µl Bradford 
solution + 100  µl water. The same procedure was applied to aliquots of crude and partially 
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purified enzyme extracts, and protein concentrations were determined from the calibration 
curve. 
 
 
3.2.3    Enzyme assay  
 
 
The standard prenyltransferase assay was carried out in a final volume of 250 µl containing 
1 mM  2,4,6 trihydroxyisobutyrophenone, 2 mM DMAPP, 10 mM FeCl2 and 0.1 M Tris-HCl 
buffer (pH 7.5). The reaction was initiated by addition of an aliquot of enzyme preparation. 
After incubation for 30 min at 37°C, the products were extracted twice with 0.5 ml ethyl 
acetate by vigorous mixing for 1 min and centrifugation at 13.000 rpm for 5 min. The organic 
phase was evaporated to dryness and the residue analyzed by HPLC. 
 
 
 
3.2.4    Enzyme preparation for ultracentrifugation 
 
 
For the preparation of microsomes, 6 ml crude enzyme extract (0.9 mg protein /ml) were  
centrifuged at 100 000 g for 30 min. The pellet was resuspended in 2.5 ml phosphate buffer 
(0.1 M, pH 6.5) containing 1 mM DTT. 
 
3.2.5    Linearity with protein amount and incubation time 
 
 
The amount of enzymatically formed dimethylallylphlorisobutyrophenone was determined  
as a function of the protein amount in the standard assay ( 20 µg, 40 µg, 80 µg, 100 µg, 150 
µg) and the incubation time (0.5, 10, 20, 30, 40, 50, 60 min). All incubations were performed 
in duplicate and average values were calculated. 
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3.3.   Characterization of the prenyltransferase   
 
 
3.3.1    Determination of pH and temperature optima 
 
 
Enzyme assays were carried out at pH values from 5.0 to 11.0 using two buffers for optimum  
buffer capacity, 0.1 M phosphate buffer (5-7) and 0.1 M Tris-HCL buffer (7.5- 11).  At the  
optimum pH value, another series of incubations were performed at different temperatures  
between 15 to 55 °C. 
 
 
 
3.3.2    Study of substrate specificity 
 
 
At the pH and temperature optima, enzyme assays were performed using a series of prenyl 
donors and prenyl acceptors. All substrate concentrations were saturating. 
 
 
 
3.3.3    Cofactor requirement 
  
 
The divalent metal ions (Fe2+,  Mg2+ ,  Zn2+,  Cu2+, Ca2+,  Mn2+, Co2+) were tested as their  
chloride salts at concentrations of 10 mM in the  presence and  absence of  10 mM  
ascorbic acid as reducing agent.  
 
 
 
3.3.4    Determination of Km values 
 
 
The kinetic properties were calculated from Lineweaver-Burk plots. For DMAPP, the  
concentration was changed between 0.2 and 16 mM while that of phlorisobutyrophenone was  
kept constant at 2 mM. For phlorisobutyrophenone, the concentration varied between 0.1 and  
8 mM while the assays contained 2 mM DMAPP. For ferrous, the concentration was changed  
between 1 and 20 mM while the assays contained 2 mM DMAPP and 2 mM phlorisobutyro- 
phenone. Two independent experiments were performed and mean values calculated. 
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3.4.    Purification of the prenyltransferase 
 
 
 
All steps of the purification were carried out at 0-4°C (on ice, in the refrigerator). Before  
samples were loaded on a column they were filtered through  an unsterile membrane  filter 
(25 mm, 0.45 µm pore diameter; Roth, Karlsruhe) to avoid clogging of FPLC columns. 
 
 
 3.4.1.1     Ammonium sulphate precipitation 
 
 
Cell-free extract (50 ml) obtained from 100 g of freshly harvested cells was fractionated by  
addition of ammonium sulphate in 10 % steps up to 70 % saturation. The enzyme extract  
was mixed with fine powder of ammonium sulphate under continuous stirring at 4°C for 30  
min and centrifuged at 9000 rpm for 35 min. The protein pellet was dissolved in 2.5 ml  
phosphate buffer pH 7.5 and desalted by passing through a PD10 column equilibrated with    
Tris-HCl buffer pH 7.5. This buffer (3.5 ml) was also used to elute the high molecular mass   
fraction. The protein fraction precipitating between 30-65 % ammonium sulphate saturation 
was used for the next  purification step. 
 
 
3.4.1.2    DEAE-anion exchange chromatography 
 
 
 
3.4.1.2.1    DEAE-column with 1 ml gel volume 
 
 
Cultured cells (20 g) were homogenized in 10 ml extraction buffer (2.1.3) and the crude 
extract (17 ml) was fractionated by addition of ammonium sulphate. The protein fraction 
which precipitated between 30-65 % saturation (3.4.1.1) was dissolved in 2.5 ml extraction 
buffer and desalted by passing through a PD10 column equilibrated with DEAE starting 
buffer (2.1.4). The same buffer (3.5 ml) eluted the protein fraction which was applied to a 
SepharoseTM  Fast Flow DEAE column (weak anion) with 1 ml gel volume (Amersham 
Bioscience). Unbound proteins were removed by washing with three bed volumes of DEAE 
starting buffer and bound proteins were eluted with a linear gradient from 0-0.5 M KCl, i.e 
increasing volumes of DEAE elution buffer (2.1.4). The total gradient volume was 20 ml and  
the flow rate  2ml/min. Fractions of 1 ml were collected. The FPLC program for this 
chromatographic separation is given in Table 3-13. 
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Tab. 3-13: FPLC program for a 1ml-DEAE- anion exchange column 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Step Time[min] Function Buffer Volume /Flow 
1 13.0 collect fractions within 1 time window ending at 33 ml 
2 0.0 UV Lamp                 ON 
3 0.0 Set zero baseline        UV detector                           
4 
0.0 isocratic flow Start buffer       100 % 
Elution buffer          0 % 
vol. 4.0 ml 
flow 2 ml/min 
5 
4.0 load/inject 
sample 
load sample 
static loop auto inject valve 
vol. 3.0 ml 
0.5 ml/min 
6 
7.0 isocratic flow Start buffer       100 % 
Elution buffer          0 % 
vol. 6.0 ml 
2 ml/min 
7 
13.0 linear gradient Start buffer          100 %→0 % 
Elution buffer       0 %→100 % 
vol. 20.0 ml 
2 ml/min 
8 
33.0 isocratic flow Start buffer              0 % 
Elution buffer        100 % 
vol. 4.0 ml 
2 ml/min 
9 
37.0 isocratic flow Start buffer             100 % 
Elution buffer            0 % 
vol. 6.0 ml 
2 ml/min 
10 37.0 End of protocol   
11 37.0  UV Lamp OFF  
 Materials and Methods                                                                                                             32                        
3.4.1.2.2    DEAE-column with 5 ml gel  
 
The procedure described under (3.4.1.2.1) was used, except that 60 g cells and a 5 ml column  
were employed. Furthermore, the volume of the total gradient was 50 ml and the flow rate 
2ml/min. Fractions of 3 ml were collected. The FPLC program for this chromatographic 
separation is given in Table 3-14. 
 
 
Tab. 3-14: FPLC program for a 5ml-DEAE- anion exchange column 
 
 
 
 
 
 
 
 
 
 
 
 
Step  Time[min] Function Buffer Volume /Flow 
1 40.0 collect fractions within 1 time window ending at 90 ml 
2 0.0 UV Lamp                 ON 
3 0.0 set zero baseline       UV detector 
4 
0.0 isocratic flow Start buffer       100 % 
Elution buffer          0 % 
vol. 15.0 ml 
flow 2 ml/min 
5 
15.0 load/inject 
sample 
load sample 
static loop auto inject valve 
vol. 5 ml 
0.5 ml/min 
6 
20.0 isocratic flow Start buffer       100 % 
Elution buffer          0 % 
vol. 20.0 ml 
2 ml/min 
7 
40.0 linear gradient Start buffer          100 %→0 % 
Elution buffer       0 %→100 % 
vol. 50.0 ml 
2 ml/min 
8 
90.0 isocratic flow Start buffer              0 % 
Elution buffer        100 % 
vol. 15.0 ml 
2 ml/min 
9 
105.0 isocratic flow Start buffer             100 % 
Elution buffer            0 % 
vol. 15.0 ml 
2 ml/min 
10 120.0 End of protocol   
11 120.0  UV Lamp OFF  
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3.4.1.3    Hydroxylapatite adsorption chromatography 
 
 
Cells (60 g) were extracted with 30 ml extraction buffer (2.1.3) and the protein extract (17 
ml) was fractionated by addition of ammonium sulphate. The protein fraction which 
precipitated between 30-65 % ammonium sulphate saturation (3.4.1.1) was dissolved in 7.5  
ml extraction buffer and desalted by  passing through a PD10 column equilibrated with  HAP  
starting buffer (2.1.4). The high molecular mass fraction was eluted with 3.5 ml of the same  
buffer and applied to a Bio-Scale Ceramic Hydroxyapatite®-Column type I (10 x 64 mm, Bio- 
Rad). Unbound proteins were removed by washing with three bed volumes of HAP starting  
buffer and bound proteins were then eluted with a linear gradient from 10-500 mM  phosphate  
by increasing the percentage of HAP elution buffer (2.1.4). The total volume of the gradient  
was 50 ml at a flow rate of 2 ml/min. Fractions of 3 ml were collected. 
 
 
 
3.4.1.4    Hydrophobic interaction chromatography 
 
 
Protein extraction and ammonium sulphate fractionation were as described under (3.4.1.2.1). 
The protein eluted from the PD10 column in HIC starting buffer (2.1.4) was applied to a 
Phenyl Sepharose® HP-column with 1 ml gel volume (Amersham Bioscience) also 
equilibrated with HIC starting buffer. Unbound proteins were removed by washing with three 
bed volumes of the same buffer and bound proteins were eluted with a linear gradient from 1 
M (NH4)2SO4 (100 % HIC start buffer) to 0 M (NH4)2SO4 (100 % HIC elution buffer). The 
gradient volume was 20 ml at a flow rate of 2 ml/min. Fractions of 1 ml were collected. 
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3.4.1.5    Mono-Q anion exchange chromatography 
 
 
Cultured cells (15 g) were extracted with 7.5 ml extraction buffer (2.1.3) and the enzyme  
extract (14 ml) was fractionated by addition of ammonium sulphate. The protein pellet  
obtained between 30-65 % saturation (3.4.1.1) was dissolved in 2.5 ml extraction buffer and  
desalted by passing through a PD10 column equilibrated with  Mono-Q starting buffer (2.1.4).  
The same buffer (3.5 ml) served to elute the protein fraction which was applied to a  
SepharoseTM Fast Flow Mono-Q column (strong anion) with 1ml gel volume (Amersham  
Bioscience). Unbound proteins were desorbed by washing with three bed volumes of Mono-Q  
starting buffer and bound proteins were eluted with a linear gradient from 0-0.5 M KCl by 
increasing the percentage of Mono-Q elution buffer (2.1.4). The gradient volume was 20 ml at  
a flow rate of 2 ml/min. Fractions of 1 ml were collected. 
 
 
 
3.4.1.6    Gel filtration 
 
 
For molecular mass estimation and as one step in the purification protocol, a HiPrep16/60  
Sephacryl S-200 High Resolution column was used. Determination of the molecular mass 
requires preceding calibration of the column by using standard proteins :  
 
 
- Albumin, Bovine serum, 66 kDa 
 
- Alcohol dehydrogenase, Yeast, 150 kDa 
 
- β-Amylase, Sweet Potato, 200 kDa 
 
- Blue dextran, 2000 kDa 
 
- Carbonic anhydrase, Bovine erythrocytes, 29 kDa 
 
- Cytochrome c, Horse heart, 12.4 kDa 
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The column was equilibrated with 50 mM Tris –HCl, pH 7.5 containing 100 mM KCl. 
To determine the void volume (Vo), blue dextran (2000 kDa) was dissolved in equilibration  
buffer (2 mg/ml) and passed through the gel filtration column at a flow rate of 0.3 ml/min.  
The fraction volume was 5 ml. To determine the elution volume (Ve) of the standards, the 
proteins were dissolved in equilibration buffer at the following concentrations (Tab. 3-15). 
 
 
Tab. 3-15: Recommended concentrations of standard proteins 
 
 
Standard protein  Concentration used 
Albumin 
Alcohol dehydrogenase 
β-Amylase 
Carbonic anhydrase 
Cytochrome c 
 
10 mg/ml 
5 mg/ml 
4 mg/ml 
3 mg/ml 
2 mg/ml 
  
 
 
The individual samples (2 ml) were applied to the column. A standard curve was calculated  
by plotting the molecular mass vs. Ve/Vo for each standard protein. 
To estimate the relative molecular mass of prenyltransferase, a crude extract from 20 g cells  
was subjected to ammonium sulphate precipitation and DEAE chromatography. The fractions  
with highest  prenyltransferase activity were combined and applied to the gel filtration  
column under the above conditions for blue dextran and protein standards. After measuring  
which fractions contain the enzyme activity, the elution volume (Ve) of the prenyltransferase  
and the Ve/Vo value were determined. The relative molecular mass was concluded from the  
standard curve. 
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3.4.2    Purification of the prenyltransferase to apparent homogeneity 
 
 
A large batch of cell suspension cultures (1379 g) was grown in BDS medium (2.2.1)   
harvested (2.2.2) and extracted (3.2.1). The chromatographic steps described above were  
combined in the following order : 
 
1)  Ammonium sulphate precipitation 
 
2)  DEAE-anion exchange chromatography (column with 5 ml gel volume) 
 
3)  Hydroxylapatite-adsorption chromatography (column with 5 ml gel volume) 
 
4)  Hydrophobic interaction chromatography (column with 1 ml gel volume) 
 
5)  Mono-Q anion exchange chromatography (column with 1 ml gel volume) 
 
6)  Gel filtration 
 
Active fractions were localized by measuring prenyltransferase activity, pooled and passed  
through PD10 columns equilibrated with the starting buffer for the next column 
chromatography. 
 
  
 
3.5.    SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
 
SDS-PAGE is used to determine the grade of purity and the subunit molecular mass of  
proteins. These were denatured by heating   in the presence of the anionic detergent SDS and  
SH reagent to reduce S-S bonds. Thereby, the proteins are uniformly negatively charged  
and disrupted into subunits, respectively. While migrating towards the anode, they are  
separated according to their molecular mass (Laemmli, 1970).     
 
 
 
3.5.1    Preparation of gel and samples 
 
 
Polyacrylamide gels are formed by cross-linking the acrylamide monomer with N´- 
methylene bisacrylamide promoted by the addition of ammoniumpersulfate (APS) and  
TEMED (N, N, N´, N´-Tetramethylethylenediamine). TEMED also acts as stabilizing agent.  
First, the applied protein mixture is concentrated in a highly porous stacking gel and then  
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separated in the resolving gel. The concentration of acrylamide and bisacrylamide in the 
resolving gel was 12% (2.1.4) which allowed high resolution of proteins between 70 and 12  
kDa. Immediately after the addition of APS and TEMED, the mixture for the resolving gel  
was poured between two vertically oriented glass plates in a gel-casting stand to make a gel of  
0.75 mm thickness. Protein samples to be analysed were mixed with protein loading buffer  
(ratio 1:2) and denatured at 95°C for 5 min, followed by loading the samples into the wells of  
the stacking gel. The maximum capacity of the wells depended on the tooth number of the  
comb used to cast the gel, e.g. 15 µl for a 24 –tooth comb. 
 
 
 
3.5.2    Electrophoresis and detection of the protein bands 
 
 
Electrophoresis was carried out on a Minigel –Twin Electrophoresis system (Biometra). The  
gel was run in 1x SDS electrode buffer at 200 V, 75 mA and 15 W supplied by a Multidrive  
XL-power supply (Pharmacia) for approximately 90 min. 
 
The protein bands were visualized by two methods: 
 
 
1- Coomassie Blue staining: 
 
Incubate the gel in Coomassie Blue staining solution (1.2.4) for 60 min or overnight,      
followed by destaining for 60 min in a destaining solution (1.2.4).  
 
 
2- Silver staining: 
 
Process the gel according to the steps given in (Table 2-16). Use 250 ml of each solution 
(1.2.4) per gel. The timing of the steps differs according to the type of solution and is 
indicated in the table. Shake slowly on a shaker or rocker  
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Tab. 3-16: Silver staining protocol  
 
 
 
 
 
3.6. Two-dimensional (2-D) electrophoresis 
  
  
  
2-D electrophoresis is a powerful and widely used method for the analysis of complex protein  
mixtures extracted from cells, tissues, or other biological samples. The technique sorts  
proteins according to two independent properties in two discrete steps: the first-dimension  
step, isoelectric focusing (IEF), separates proteins according to their isoelectric points (pI).  
The second-dimension step, SDS-PAGE, separates proteins according to their subunit  
molecular masses (Mr). Each spot on the resulting two-dimensional array corresponds to a  
single protein species in the sample. The power of 2-D electrophoresis as a biochemical  
separation technique has been improved to achieve rapid analysis of proteins. 
Single spots eluted or transferred from 2-D gels can be rapidly identified. Mass spectrometric  
techniques have been developed that allow analysis of very small quantities of peptides and  
Solution Time for gel incubation 
 
Fixing solution 
 
 
 
40-60 min 
 
Sensitizing solution 
 
 
 
60 min or over night 
 
Distilled  water 
 
3 x 5 min 
 
Silver solution 
 
 
30 min 
 
Distilled  water 
 
2  x 2 min 
 
Developing solution 
 
 
Until protein bands are visible (5-10 min) 
 
Stop solution 
 
10 min 
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proteins. Chemical microsequencing and amino acid analysis can be performed on  
increasingly smaller samples. Immunochemical identification is now possible with a wide  
assortment of available antibodies. 
 
 
 
 
3.6.1    Sample preparation 
  
 
 
The protein fraction to be loaded on a 2-D gel must be present in a low ionic strength  
denaturing buffer that maintains the native charges of proteins and keeps them soluble. 
Salt is the major cause of poor focusing in isoelectric focusing (IEF) and increases focusing  
time, as proteins will migrate to their pI only after the ions have moved out of the strips. 
The salt is easily removed by protein precipitation using TCA. 
 
TCA precipitation protocol: 
 
1) Mix an aliquot of the purified protein (500 µl) with trichloroacetic acid (TCA)  to give  
      a 13% final concentration. Keep 5 min at -20°C and then 15 min at 4°C. 
 
 
2) Spin 15 min at 4°C in a microcentrifuge at maximum speed (15000 g). Carefully  
       discharge the supernatant and retain the pellet. 
 
 
3) Wash the pellet with 200 µl cold acetone, spin 5 min at 15000 g.  
 
4)  Repeat step 3 twice, dry tube by inversion on tissue paper. 
  
  
 
3.6.2    First–dimension isoelectric focusing (IEF) 
  
 
 
1. Resuspend the pellet in 85 µl rehydration buffer a (2.1.6.). 
 
2. Add 45 µl rehydration buffer b (2.1.6.) and mix. 
 
3. Pipet the indicated volume (125 µl) of the sample as a line along the back edge of a channel  
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 in rehydration tray. The line of sample should extend along the whole length of the channel  
except for 1 cm at each end. Avoid to introduce any bubbles which may interfere with the  
even distribution of the sample in the strip. 
 
4. Peel the coversheet from ReadyStrip IPGstrip (pH 3-10) using forceps, gently place it, gel  
side down, onto the sample. The “+” and the pH range marked on the strip should be legible  
and also take care not to trap air bubbles beneath the strip. If this happens, carefully use the  
forceps to lift the strip up and down from one end until the air bubbles move to the end and  
out from under the strip.  
 
5. Wait for approximately 1 hr after starting rehydration, until most of the liquid has been  
absorbed by the strip. Then overlay the strip with 2-3 ml mineral oil to prevent evaporation  
during the rehydration process. 
 
6. Cover the rehydration tray with the plastic lid provided and leave the tray sitting on a level  
bench overnight (11-16 h) to rehydrate the IPG strip and load the protein sample. 
 
7. Place a clean, Multiphor™ II Electrophoresis unit onto the lab bench, using forceps, place  
wick at both ends of wire eclectrodes, pipet 8 µl of bidistilled water onto each wick to wet  
them.  
 
 
8. Remove the IPG strip from rehydration tray using forceps, carefully hold the strip vertically  
for about 7-8 sec. And blot the tip of the strip on a piece of filter paper to allow the mineral  
oil to drain, then transfer the IPG strip to the cooling plate in the Multiphor™ II, maintain the  
gel side down and the “+” marked on the strip should be positioned at the side of the plate 
 “+” marked  
 
 9. Cover the IPG strip with 2-3 ml fresh mineral oil. Try to avoid air bubbles.  
 
10. Place the lid on the Multiphor II unit and connect the leads on the lid to the power supply  
and begin focusing program  (Tab. 3-17) at 20 °C, 2 steps. 
 
 
 
 
 
 
 Materials and Methods                                                                                                             41                        
Tab. 3-17: Focusing program 
 
Step      Voltage (V)        Current (mA)       Power (W)       Duration (h:min)      Duration (vh) 
 1              250                   00.1                        0.3                            1:30               150 
 
  2             300                    00.1                        0.3                            0:30               9000 
 
 
 
 
                                                                
3.6.3    Second-dimension SDS-PAGE 
  
 
 
Prior to running the second dimension, it is necessary to equilibrate the IPG strip in a buffer 
that contains SDS. 
 
1. Remove the mineral oil by placing the IPG strip (gel side up) onto a piece of dry filter 
    paper and blotting with a second piece of wet filter paper. 
 
2. Transfer the blotted IPG strip (gel side up) to the equilibration tray and add 5 ml SDS- 
    equilibtion buffer containing DTT (2.1.6.). 
 
3. Place the tray on a shaker and gently shack for 15 min. 
 
4. Discard the SDS equilibration buffer with DTT from the tray and add 5 ml SDS  
equilibration buffer containing iodoacetamide (2.1.6).  
  
5. Return the tray to the shaker for 15 min. 
 
 6. Discard the SDS equilibration buffer with iodoacetamide from the tray by decanting at the     
       end of the incubation period. 
7. Finish preparing the SDS-PAGE gel by blotting away any excess of water remaining   
    inside the IPG well using blotting paper. 
 
8. Remove an IPG strip from the equilibration tray and dip briefly into the graduated  
    cylinder containing 1x SDS electrode buffer (1.2.5.). 
 
 
9. Lay the IPG strip onto the back of the SDS-PAGE gel above the IPG well, using a spatula  
    to push carefully the IPG strip into the well, try to avoid air bubbles. 
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10. To ensure good contact between the gel and the IPG strip, overlay it with 0.5-1.0 %  
       molten agarose solution prepared in 1x SDS electrode buffer (1.2.5.). A small  
       amount of Bromophenol Blue can be added to the agarose overlay in order to track 
       the ion front during the run. 
 
11. Load the gel into the electrophoresis cell and fill the reservoirs with 1x SDS electrode                                                                
      buffer (1.2.5.) and begin the electrophoresis, at constantly 200 V. The approximate         
      running time is 35 min. 
 
            
3.6.4    Detection and analysis of 2-D protein spots 
 
 
Protein spots were visualized by staining with Coomassie Blue (3.5.2.). The 2-D gel was  
placed on a light box and  the protein spots were cut off with a spatula. The gel pieces were  
t ransferred into eppendorf  tubes  and washed with dis t i l led water  5  t imes.  
After drying in a speed vacuum concentrator, the gel pieces were preserved in a freezer at –20 
ºC. Tryptic digest and partial sequencing were kindly performed by Dr. Nimtz, GBF 
(Gesellschaft  für Biotechnologische Forschung), Braunschweig.  
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4.    Results 
 
4.1.    Detection of prenyltransferase activity 
 
 
Cell–free extracts from 3-day-old H. calycinum cell cultures (3.2.1; 3.2.2) were incubated 
with phlorisobutyrophenone and DMAPP in the presence of FeCl2 (3.2.3). These incubations 
resulted in the formation of an enzymatic product, as demonstrated by HPLC (Fig. 4-1) and 
GC-MS analysis (Fig. 4-2). No enzymatic product was detected when boiled protein extract 
was used and either phlorisobutyrophenone or DMAPP was omitted.   
a) 
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                                                                     S 
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                                                                                                       R 
 
 
 
Fig.  4-1: HPLC analysis of prenyltransferase assays with phlorisobutyrophenone. 
                                    Detection wavelength 291 nm 
          a) Standard assay 
            b) Incubation with denatured protein 
          c) Reference compound dimethylallylphlorisobutyrophenone 
                                    P = Enzymatic product (dimethylallylphlorisobutyrophenone) 
                                S = Substrate (phlorisobutyrophenone) 
                                R = Reference compound   
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Fig. 4-2: GC-MS analysis of prenyltransferase assays. The control assay contained heat-
denatured protein. The enzymatic product and the synthetic reference compound were 
acetylated. 
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4.1.1    Synthesis of the reference compound dimethylallylphlorisobutyrophenone 
 
 
The hyperforin skeleton is phlorisobutyrophenone which is stepwise prenylated. The expected 
product of the first prenylation step is dimethylallylphlorisobutyrophenone (3-(3-methyl-2-
butenyl)-2,4,6-trihydroxyisobutyrophenone) [C15H20O4]. This compound was not 
commercially available as reference compound and thus had to be synthesized chemically.  
The synthesis and the purification of the reaction product are described under (3.1.2) and 
(3.1.2.1), respectively. The purified product showed an absorption maximum at 291 nm (Fig. 
4-3). Its molar mass was 264.07 g/mol (Fig. 4-4). 
 
 
                          
Fig. 4-3: UV spectrum of the synthetic reference dimethylallylphlorisobutyrophenone 
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       Fig. 4-4: Mass spectrum of the synthetic reference dimethylallylphlorisobutyrophenone 
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Fig. 4-5: 1H NMR spectrum of the synthetic reference dimethylallylphlorisobutyrophenone  
 
 
Results                                                                                                                                       47 
The 1H NMR spectrum is depicted in Fig. 4-5. In detail, the properties were as follows:  
Rf. ( silica gel, diethyl ether : pentane 60 : 40) 0.75; RI (ZB1 / ZB5) 2223 / 2274; 1H NMR  
 
(400 MHz, CDCl3) δ 1.18 (6H, d, J=7 Hz, CH3x2), 1.78 (3 H, d, J=1 Hz, CH3), 1.82 (3 H, s,  
 
CH3), 3.36 (2 H, d, J=7.2 Hz, =CH-CH2), 3.8 (1H, qq, -CH-(CH3)2), 5.25 (1H, m, =CH) 5.8 (1  
 
H, s, Carom.H); EIMS, 70eV, m/z (rel. int.): 264 (18, [M]+),  221 (39), 209 (6), 191 (3), 177 (3),  
 
165 (100), 153 (5),  69 (5), 55(3), 43 (3). 
 
These spectroscopic properties of 3-(3-methyl-2-butenyl)-2,4,6-trihydroxyisobutyrophenone 
agreed with the literature (Kuhnke and Bohlmann,  1985; Fung  et al., 1994).  
 
 
 
4.1.2    Analysis of the enzymatic product dimethylallylphlorisobutyrophenone 
 
 
 
The enzymatic product was extracted from large-scale incubations, purified by TLC (3.1.2.2) 
and analyzed by GC-MS (3.1.2.4).  
In comparison with the sample of chemically synthesized reference compound, it was 
identified as dimethylallylphlorisobutyrophenone. The synthetic compound and the enzymatic 
product exhibited identical retention times and mass spectra. This was also true for their 
acetylated derivatives (Fig. 4-1).  
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4.2.    Characterization of the prenyltransferase 
 
 
4.2.1     Linearity with protein amount and incubation time 
 
The prenyltransferase reaction was linear with a protein amount up to 80 µg in the assay 
(Table 4-1) and with time up to 30 min (Fig. 4-6). Product amounts were determined by 
HPLC using a standard solution of the synthetic reference compound. 
 
Table 4-1: Effect of the amount of protein in the standard assay  
                         on the amount of enzyme product. 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
                           
 
                        
                          
                 
 
          Fig. 4-6: Time course of product formation in the prenyltransferase assay.  
 
 
 
 
 
Amount of protein (µg) Amount of product (ng) 
20 µg 
 
56 ng 
40 µg 
 
65 ng 
80 µg 
 
108.7 ng 
100 µg 
 
182.6 ng 
150 µg 
 
106.6 ng 
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4.2.2    Determination of pH and temperature optima 
 
 
The enzyme showed a broad pH optimum from 6.5 to 9 (Fig. 4-7), and a temperature 
optimum around 38 oC (Fig. 4-8). An incubation temperature of 37 °C and pH 7.5 were   used 
for the following experiments of enzyme characterization. 
 
  
            
 
              
 
 
 
   
 
 
 
 
 
 
 
 
 
                                         
                           
                                        Fig. 4-7: pH optimum of prenyltransferase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                            Fig. 4-8: Temperature optimum of prenyltransferase.  
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4.2.3    Cofactor requirement 
 
Prenyltransferase activity was strictly dependent on a divalent cation, with Fe2+ being  
the most efficient cofactor (Fig.4-9). Lower activities were observed with Mg2+, Zn2+, and  
Cu2+.  No activity was found in the absence of a divalent cation. Prenyltransferase activity 
increased with increasing concentration of Fe2+ (Fig. 4-10). Concentrations higher than 10 
mM, however, had an inhibitory effect on the enzyme activity.  
The Km value was 3.8 mM, as calculated from a Lineweaver-Burk plot (Fig. 4-11). Because 
of its inhibitory effect, the 20 mM concentration was omitted from the double-reciprocal plot. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   a   Detection limit: 1 ng  
 
           Fig. 4-9: Effect of divalent cations on dimethylallyltransferase activity. Bars  
             represent means and standard deviations from three independent determinations. 
 
 
 
 
 
 
4.2.4    Effect of ascorbic acid 
 
 
To find out whether or not the preference of the enzyme for ferrous was due to the reducing 
properties of this ion, assays in the presence and the absence of 10 mM ascorbic acid were 
carried out. Both experiments gave the same result.  
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              Fig. 4-10: Dependence of dimethylallyltransferase activity on the   
                                             concentration of Fe 2+.   
 
              
  
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Fig. 4-11: Determination of the Km value for Fe 2+ from a Lineweaver-Burk plot.                                                                                                                                
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4.2.5    Substrate specificity 
 
 
The transferase used DMAPP as the prenyl donor. Product formation also occurred in the 
presence of IPP, but this was attributed to IPP isomerase activity in the crude extract. No 
enzyme activity was observed with GPP, FPP, and GGPP as prenyl donors. The preferred 
prenyl acceptor was phlorisobutyrophenone. High transferase activity was also found with 
phloracetophenone. 
No enzyme activity was observed with phloroglucinol as prenyl acceptor (Table 4-2). 
 
 
Table 4-2:  Substrate specificity of phlorisobutyrophenone dimethylallyltransferase. 
 
 
a specific activity: 3.6 µkat/kg 
b
  Detection limit: 1  ng 
 
 
4.2.6    Synthesis of the reference dimethylallylphloracetophenone  
 
 
The expected product from the prenylation of phloracetophenone was dimethylallyl- 
phloracetophenone (3-(3-methyl-2-butenyl)-2,4,6-trihydroxyacetophenone). Since this 
compound was not commercially available as a reference, it had to be synthesized chemically 
(3.1.3). The purified (3.1.3.1) product (C13H16O4) had an absorption maximum at 291 nm 
(Fig. 4-12) and a molar mass of 236 g/mol (Fig. 4-13). 
 
 
 
Prenyl donor Rel. enzyme 
activity (%) 
Prenyl acceptor Rel. enzyme 
activity (%) 
dimethylallyl diphosphate (DMAPP) 
isopentenyl diphosphate (IPP) 
geranyl diphosphate (GPP) 
farnesyl diphosphate (FPP) 
geranylgeranyl diphosphate (GGPP) 
100a 
30 
< 0.3b 
< 0.3b 
< 0.3b 
phlorisobutyrophenone 
phloracetophenone 
phloroglucinol 
100a 
80 
< 0.3b 
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Fig. 4-12: UV spectrum of the synthetic reference dimethylallylphloracetophenone 
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   Fig. 4-13: Mass spectrum of the synthetic reference dimethylallylphloracetophenone               
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The 1H NMR spectrum of dimethylallylphloracetophenone is shown in Fig. 4-14. 
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Fig. 4-14: 1H NMR spectrum of the synthetic reference dimethylallylphloracetophenone  
 
The spectroscopic data of 3-(3-methyl-2-butenyl)-2,4,6-trihydroxyacetophenone corresponded 
to published data (Jakupovic  et al., 1986). They are summarized as follows: 
Rf. ( silica gel, diethyl ether : pentane  60 : 40 ) 0.44; RI (ZB5) 2177; 1H NMR (400 MHz,  
 
CDCl3) δ 1.78 (3 H, s, CH3), 1.83 (3 H, s, CH3), 2.66 (3 H, s, COCH3), 3.36 (2 H, d, J=7.2  
 
Hz, CH-CH2), 5.25 (1H, m, =CH-CH2), 5.83 (1 H,s, Carom.H); EIMS, 70eV, m/z (rel. int.):  
 
181 (100, [M-C4H7]+), 236 (88, [M]+), 165 (34), 221 (32, [M-CH3]+), 193 (32, [M-CH3CO]+),  
 
163 (20), 43 (18), 153 (14), 203 (11), 182 (9), 69 (9),168 (7). 
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4.2.7    Analysis of the enzymatic product dimethylallylphloracetophenone 
 
 
The product resulting from the monoprenylation of phloracetophenone was identified as 
dimethylallylphloracetophenone by HPLC (Fig. 4-15) in comparison with a sample of the 
synthesized reference compound. The enzymatic product was extracted from large-scale 
incubations, purified by TLC and analyzed by GC-MS (Fig. 4-16). The synthetic reference 
compound and the enzymatic product exhibited identical mass spectra and retention times. 
 
                                                                        
a) 
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 b)                                                                                
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                                                                                                          R 
 
 
 
Fig.  4-15: HPLC analysis of prenyltransferase assays with phloracetophenone. 
                                    Detection wavelength 291 nm 
          a) Standard assay 
            b) Incubation with denatured protein 
          c) Reference compound dimethyallylphloracetophenone 
 
                              P = Enzymatic product (dimethylallylphloracetophenone) 
                                S = Substrate (phloracetophenone) 
                                R = Reference compound   
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d) 
 
 
 
 
 
 
e) 
 
 
 
 
 
          
 
 Fig.  4-16: GC-MS analysis of the enzymatic product dimethylallylphloracetophenone and 
the synthetic reference compound (after acetylation). GC of enzymatic product (a) and 
reference compound (c), Co- chromatography (b). Mass spectra of the enzymatic 
product (d) and the reference compound (e). 
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4.2.8    Determination of kinetic data 
 
 
Prenylation of phlorisobutyrophenone followed Michaelis-Menten kinetics and the Km values 
were calculated from Lineweaver-Burk plots. 
For phlorisobutyrophenone, the concentration varied between 0.1 and 8 mM while the assays 
contained 2 mM DMAPP (Fig.4-17). The Km value was 0.52 mM (Fig. 4-18). Two 
independent experiments were performed and mean values calculated. 
 
 
 
 
                
 
 
 
 
 
 
 
       
                  Fig. 4-17: Dependence of dimethylallyltransferase activity on the  
                                                  concentration of phlorisobutyrophenone.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              Fig. 4-18: Determination of the Km value for phlorisobutyrophenone   
                                                        from a Lineweaver-Burk plot. 
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For DMAPP, the concentration was changed between 0.2 and 16 mM while that of 
phlorisobutyrophenone was kept constant at 2 mM (Fig. 4-19). The increase in 
prenyltransferase activity obeyed Michaelis-Menten kinetics. High DMAPP concentration 
inhibited the enzyme. These data points were not included in the Lineweaver-Burk plot. The 
Km value was 0.46 (Fig. 4-20). Two independent experiments were performed and mean 
values calculated. 
 
 
   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  Fig.  4-19: Dependence of dimethylallyltransferase activity on the  
                                                  concentration of DMAPP.                        
 
 
 
 
 
                     
  
 
 
 
 
 
 
 
 
 
 
        Fig.  4-20: Determination of the Km value for DMAPP from a Lineweaver-Burk plot. 
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4.2.9    Prenyltransferase activity in cell fractions after ultracentrifugation 
 
 
After ultracentrifugation, 80 % of the enzyme activity was found in the supernatant (Table 4-
3). The specific activity in the supernatant was more than 20 times that in the pellet. These 
data indicate that the enzyme involved in hyperforin biosynthesis is a soluble 
dimethylallyltransferase. 
 
Table 4-3: Prenyltransferase activity in cell fractions after ultracentrifugation. 
 
 
 
 
 
 
4.2.10    Changes in prenyltransferase activity and adhyperforin formation during cell  
 
                 culture growth 
 
 
The accumulation of hyperforins in H. calycinum cell cultures occurred between day 3 and 6  
(Klingauf et al., 2005). It was preceded by an increase in dimethylallyltransferase activity. 
The maximum specific enzyme activity was 3.6 µkat/kg protein and observed at day 3 (Fig. 4-
14). Thereafter, the enzyme activity decreased and declined completely during the stationary 
phase. 
 
 
 
 
 
 
 
 
 
 
 
     Cell fraction                         Protein          Total activity                   Specific activity  
                                                   (mg)            pkat              %                      (µkat /kg ) 
 
Crude cell-free extract               5.5          19.64            100                      3.57 
 
Supernatant (100 000 g)             4.9          15.74              80                      3.213 
 
Pellet (100 000 g)                       0.5          0.0714           0.36                   0.1428 
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             Fig. 4-21: Adhyperforin formation and changes in prenyltransferase activity  
                during cell culture  growth. Values are means of  two independent experiments. 
      
 
 
 
 
 
 
4.3.    Purification of the prenyltransferase 
 
 
 
4.3.1    Fractionation by ammonium sulphate precipitation 
 
 
The majority of prenyltransferase activity was precipitated between 30 and 65% saturation 
(Fig. 4-22). This fraction was used for subsequent column chromatographies.  
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                Fig. 4-22: Distribution of prenyltransferase activity in ammonium sulphate-       
                                                              precipitated protein fractions. 
 
 
 
 
 
 
4.3.2    Column chromatography   
 
 
 
The protein fraction precipitating between 30 and 65% ammonium sulphate saturation was 
subjected to various column chromatographies in order to test the purification efficiency of 
these procedures. 
 
 
 
4.3.2.1    DEAE-anion exchange chromatography   
 
 
 
4.3.2.1.1    DEAE-column with 1 ml gel volume  
  
 
Ion exchange chromatography was preceded by ammonium sulphate precipitation as the first 
purification step. The protein fraction precipitating between 30 and 65% ammonium sulphate 
saturation was loaded onto a DEAE-Sepharose column with 1 ml gel volume, after the buffer 
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had been exchanged for DEAE starting buffer. Bound proteins were eluted with a linear salt 
gradient from 0-0.5 M KCl. The protein elution profile is shown in Fig. 4-23. Fractions 1-7 
are related to sample application and removal of unbound proteins. Fractions 8-24 contain 
bound proteins.  
Measuring prenyltransferase activity in the individual fractions (Fig. 4-24) showed that the 
enzyme eluted between 0.3 and 0.4 M KCl (fractions 19-22), with the major fraction in the 
activity profile (fraction 21) being eluted at 0.35 M KCl.  
Fractions 19-22 that contained high prenyltransferase activity were pooled and used for the 
subsequent purification step. 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-23: Anion exchange chromatography of the protein fraction precipitating    
                    between 30 and 65% ammonium sulphate saturation on a 1 ml-DEAE- 
                    Sepharose column (Protein was measured at 280 nm) 
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      Fig. 4-24: Detection of prenyltransferase activity in protein fractions eluted  
                           from the DEAE-Sepharose column (Fig. 4-23) 
 
 
 
4.3.2.1.2    DEAE-column with 5 ml gel volume 
 
 
The use of a larger DEAE-Sepharose column (5 ml) in the first step of the purification scheme 
provided a convenient method to load larger quantities of the 30 to 65% ammonium sulphate 
precipitated protein fraction and to improve the recovery. The procedure used corresponded to 
that described above. Prenyltransferase activity was detected in the fractions eluting between 
0.3 and 0.4 M KCl. 
 
 
4.3.2.2    Hydroxylapatite-adsorption chromatography 
 
 
The prenyltransferase-containing protein fraction precipitating between 30 and 65% 
ammonium sulphate saturation was subjected to buffer exchange and subsequently loaded 
onto a hydroxylapatite column (Bio-Rad CHT5-1) equilibrated with starting buffer. Elution 
was carried out with a linear gradient from 10-500 mM phosphate buffer pH 7.5. Bound 
proteins were eluted between 60 and 250 mM phosphate (Fig. 4-25). After measuring the 
prenyltransferase activity in each fraction, the activity profile (Fig. 4-26) showed that most of 
the enzyme activity was eluted between 120 and 200 mM phosphate. Fractions showing the 
highest prenyltransferase activity were pooled and used for the subsequent purification step. 
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         Fig. 4-25: Hydroxylapatite-adsorption chromatography of the protein fraction   
                             precipitating between 30 and 65% ammonium sulphate saturation on a  
                            CHT5-1 column (Protein was measured at 280 nm) 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Fig. 4-26: Detection of prenyltransferase activity in protein fractions obtained  
                          by hydroxylapatite-adsorption chromatography (Fig. 4-25) 
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4.3.2.3    Hydrophobic interaction chromatography 
 
 
Protein from ammonium sulphate fractionation (30 to 65% saturation) was passed through a 
hydrophobic interaction chromatography column (Phenyl-Sepharose). The sample was loaded 
at a high salt concentration and elution was performed using a descending gradient (Fig. 4-
27). Proteins with low hydrophobicity did not absorb to the hydrophobic resin and therefore 
were eluted during the washing step (fractions 1-12). Bound proteins were eluted in roughly 
two peaks by decreasing the ammonium sulphate concentration in a linear gradient from 1 to 
0 M (NH4)2SO4 in phosphate buffer pH 7.5. 
 
 
 
 
Fig. 4-27: Hydrophobic interaction chromatography of the protein fraction  
                    precipitating between 30 and 65% ammonium sulphate saturation on a  
                    Phenyl- Sepharose column (Protein was measured at 280 nm) 
 
 
 
 
Prenyltransferase activity was eluted in the first peak of the descending salt gradient (0.8-0.7 
M (NH4)2SO4). Other components were more tightly bound to the hydrophobic resin and only 
eluted with buffer containing low ammonium sulphate concentrations.   
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     Fig. 4-28: Detection of prenyltransferase activity in protein fractions  
                          separated on a Phenyl-Sepharose column (Fig. 4-27) 
 
 
 
 
 
4.3.2.4    Mono-Q anion exchange chromatography 
 
Protein from ammonium sulphate fractionation (30 to 65% saturation) was passed through a 
Mono-Q anion exchange column after the buffer had been replaced by Mono-Q starting 
buffer. The profile of protein elution from the Mono-Q column is shown in Fig. 4-29. Bound 
proteins were eluted in two peaks using a linear KCl gradient from 0 to 0.5 M KCl. The 
gradient began at fraction 8 and reached 0.5 M KCl in fraction 25. 
The activity profile obtained by assaying enzyme activity in the individual fractions (Fig. 4-
30) showed that the prenyltransferase eluted in the second, smaller protein peak at KCl 
concentrations between 0.33 and 0.38 M (fractions 19-21). These fractions were pooled and 
used for further enzyme purification. 
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Fig. 4-29: Anion exchange chromatography of the protein fraction precipitating  
                    between 30 and 65% ammonium sulphate saturation on a Mono-Q  
                    column (Protein was measured at 280 nm) 
 
 
     
 
 
 
 
 
 
 
 
 
 
                 
                     Fig. 4-30: Detection of prenyltransferase activity in protein fractions      
                                         eluted from a Mono-Q column 
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4.3.2.5    Gel filtration 
 
Chromatography on a gel filtration column was used for prenyltransferase purification as well 
as determination of the native molecular mass ( 4.3.5.1). A Sephacryl 200 HR column was 
calibrated using blue dextran and the standard proteins cytochrome c, carbonic anhydrase, 
bovine serum albumin, alcohol dehydrogenase and β-amylase. Elution of blue dextran was 
used to measure the void volume (Vo), as shown in Fig. 4-31. The elution volumes (Ve) of the 
standard proteins were determined, as depicted in Fig. 4-32. To obtain a calibration curve, the 
molecular masses of the markers were plotted versus the Ve / Vo ratio (Fig. 4-33).  
 
 
 
       Fig. 4-31: Elution profile of blue dextran on a Sephacryl S-200 HR column  
                                               (Protein was measured at 280 nm) 
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   Fig. 4-32: Elution profile of standard proteins on a Sephacryl S-200 HR column   
                                                (Protein was measured at 280 nm) 
                       1: β-amylase (200 kDa), 2: alcohol dehydrogenase (150 kDa), 3: albumin    
                          (66 kDa), 4: carbonic anhydrase (29 kDa), 5: cytochrome c (12.4 kDa) 
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       Fig. 4-33: Calibration of a Sephacryl S-200 HR column 
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4.3.3      Purification of the prenyltransferase 
 
 
The chromatographic steps described above were combined as shown in Fig. 4-34. After each 
step, the active fractions were localized by measuring prenyltransferase activity, then pooled 
and passed through PD10 columns equilibrated with the starting buffer for the next column. 
         Fig. 4-34: Diagram depicting the purification scheme applied to the  
                               prenyltransferase from H. calycinum cell cultures          
 
                                                                  Crude extract 
 
 
 
Ammonium sulphate precipitation 
                                                               (30-65 % saturation)              
               
                PD10 
 
        
       DEAE-anion exchange chromatography (5 ml)  
                                            (active fractions eluted between 0.33-0.4 M KCl) 
                                                                                               PD10 
     
                                
                                           Hydroxylapatite chromatography [HAP] (5 ml) 
                                     (active fractions eluted between 0.12 -0.2 M phosphate) 
                       
                                                                               PD10                                                                      
 
                                        
                                      Hydrophobic interaction chromatography [HIC] (1 ml) 
                                     (active fractions eluted between 0.8-0.7 M (NH4)2SO4)                                
                                         
                                                                                
                                                                                PD10 
                                                                                 
                                             Mono-Q anion exchange chromatography (1 ml) 
                                          (active fractions eluted between 0.33-0.48 M KCl)                              
 
  
                                                                  
  
                                                                     Gel filtration  
 
 
                                                        Purified prenyltransferase 
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For the final purification step, i.e. gel filtration, the active fractions after chromatography on 
the Mono-Q column were pooled and loaded onto a Sephacryl S-200 column. Three major 
protein peaks were eluted (Fig. 4-35). Prenyltransferase activity was located in the third peak 
(fraction 12). The fractions 1-11 lacked prenyltransferase activity. The protein-containing 
fractions were analyzed by SDS-PAGE in a 12% gel and protein bands were visualized by 
silver staining. Fraction 12 which contained prenyltransferase activity exhibited the highest 
grade of purity (Fig. 4-37). 
 
These results suggested that the prenyltransferase could be purified to apparent homogeneity 
using fractionating ammonium sulphate precipitation, ion-exchange chromatography on 
DEAE-Sepharose, hydroxylapatite adsorption chromatography, Phenyl-Sepharose 
hydrophobic interaction chromatography and gel-filtration. 
 
Table 4-4 summarizes the results obtained in the six step-procedures for prenyltransferase 
purification. After each chromatographic step, the protein content and the prenyltransferase 
activity were measured and the specific prenyltransferase activity was calculated. The specific 
enzyme activity in the initial crude extract (step 1) was 3.1 µkat/kg. After ammonium sulphate 
precipitation (step 2) which allowed concentration of the cell-free extract, it increased 2.5-fold 
with about 91% recovery of enzyme activity. After gel-filtration (step7), the recovery of 
preanyltransferase activity was 0.29%, accompanied by a 65-fold increase in the specific 
activity (200 µkat/kg). Hydrophobic interaction chromatography on the Phenyl-Sepharose 
column (step 5) was a highly efficient purification step because the majority of contaminants 
passed through the column without being bound. Although a considerable portion of the 
enzyme activity was lost when loading the column (from 0.54 to 0.18 nkat), the specific 
activity enhanced from 22 to 127.3 µkat/kg protein and thus the purification factor 
dramatically increased from 7.1 to 41.1.  
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Fig. 4-35: Gel filtration on Sephacryl S-200 of the prenyltransferase-containing protein  
                     fraction obtained by Mono-Q anion exchange chromatography  
                            (Protein was measured at 280 nm) 
 
 
Tab. 4-4: Purification of the prenyltransferase from  H. calycinum cell cultures 
 
a
 from 1379 g fresh weight   
 
 
 
 
Purification        Total protein    Total activity     Specific activity    Purification          Yield 
Step                        (mg)                 (nkat)                 (µkat/kg)             (-fold)                  (%) 
Crude extract        1736a                           5.4                      3.1                          1                     100 
 
(NH4)2SO4         633.4                   4.9                      7.7                         2.5                     91 
(30-65 %) 
 
DEAE                   124.9                    2.2                    17.6                        5.7                    41 
 
HAP                       24.6                    0.54                   22                            7.1                   10 
 
HIC                        1.4                      0.18                  127.3                        41.1                 3.3 
 
Mono-Q                 0.39                    0.07                   182.8                       59                   1.32 
 
Gel filtration           0.1                      0.02                    200                         65                  0.29 
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 4.3.4     SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
 
 
The degree of purification of the prenyltransferase after each chromatographic step was 
examined by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). In 
addition, the subunit molecular mass of the prenyltransferase was determined (4.3.5.2). 
 
 
4.3.4.1   Preparation of samples 
 
 
Aliquots of the active, pooled fractions after each step in the purification sequence were 
analyzed. After gel filtration, aliquots of the protein-containing fractions (10 µg each) were 
concentrated and subjected to SDS-PAGE.  
 
 
4.3.4.2   Electrophoresis and detection of protein bands 
 
 
Proteins were visualized using silver staining. Fig. 4-36 shows the complexity of the protein 
fractions at different stages of prenyltransferase purification. Initially, the samples contained a 
heterogeneous mixture of proteins (lanes 1-6). In the course of purification, the number of 
protein bands gradually decreased. The efficiency of gel filtration is evident when lanes 6 and 
7 are compared. After gel filtration, two closely spaced protein bands were observed with 
estimated molecular masses of ~ 31 kDa (Fig. 4-36 and 4-37B). These two polypeptides were 
absent from the other fractions analyzed after gel filtration (Fig. 4-37 A).  
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Fig. 4-36: SDS-PAGE (12% gel) of fractions containing prenyltransferase activity after 
the following purification steps. (1) Crude extract; (2) (NH4)2SO4 precipitation; (3) 
DEAE; (4) HAP; (5) HIC; (6) Mono-Q; (7) Gel filtration. (M) Molecular mass markers. 
Visualization by silver staining. 
 
 A                                                                                                                 B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 M             7      8       9      10      11     12   13     M                                     12      M 
 
Fig. 4-37: SDS-PAGE of the protein-containing fractions after gel filtration (A). 
Separation of a small protein quantity from fraction 12 (B). 
 4.3.5    Determination of the molecular masses  
M      1          2       3       4         5          6       7     M 
40 kDa 
30 kDa 
30 kDa 
100 kDa 
50 kDa 
10 kDa 
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4.3.5.1    Determination of the subunit molecular mass by SDS-PAGE 
 
 
The migration of the standard proteins (Fig. 4-37B) was used to derive a calibration curve 
(Fig. 4-38). The relative electrophoretic mobility of the purified protein bands indicated 
subunit molecular masses of ~ 31 and 31.5 kDa.  
 
  
            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Fig. 4-38: Determination by SDS-PAGE of the molecular masses of the two 
                             polypeptides in fraction 12 after gel filtration.  
 
                                                Positions of the two protein bands                                                      
                                                                            
 
 
4.3.5.2    Determination of the native molecular mass by gel filtration 
  
 
The purified prenyltransferase was eluted in fraction 12 (Fig.4-35). This position corresponds, 
on the basis of the calibration curve (Fig. 4-33), to a relative molecular mass of ~ 63000. This 
value was confirmed by using ammonium sulphate-precipitated protein (30-65% saturation) 
for gel filtration on a calibrated Sephacryl 200 HR column. The prenyltransferase activity was 
detected at Ve/Vo 2.03, which also indicates a relative molecular mass of ~ 63000.Thus; the 
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purified prenyltransferase appeared to be a heterodimer of the two subunits that were detected 
in SDS-PAGE. 
 
 
4.3.6    Two-dimensional (2-D) electrophoresis 
 
 
The combination of isoelectric focusing (IEF) and SDS-PAGE is regarded to be the most 
powerful separation method for resolving complex mixtures of proteins into distinct spots in a 
gel. Gel plugs of these spots can be removed and further analyzed by mass spectrometry to 
determine the identity of individual proteins. 
 
 
4.3.6.1     First-Dimension Isoelectric Focusing (IEF) 
 
 
Approximately 10 µg of the purified protein were solubilized in rehydration buffer and loaded 
onto an IPG strip (3.6.1). A pH 3–10 IPG strip allows detection of a broad spectrum of protein 
spots. 
 
 
4.3.6.2    Second-dimension SDS-PAGE 
 
 
After separation in the first dimension, the proteins were further resolved according to their 
molecular masses using a 12% gel (3.6.2) 
 
 
4.3.6.3    Detection and analysis of 2-D resolved protein spots 
 
 
Staining with Coomassie-Blue visualized four protein spots (Fig. 4-39). One of them was 
stained intensively (spot 2). The four protein spots were excised from the 2 D-gel and 
subjected to enzymatic digestion (4.3.7), leading to a series of peptides for sequencing. 
 
 
 
 
 
 
 
 
                   
Results                                                                                                                                       77 
 
 
3 4 2 1 
3 4 5 6 7 8 9 10
 
                                                                                                                      
                                                                                                                                                                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        pH 
              
 
              Fig.  4-39: Two-dimensional electrophoresis of the purified protein     
                                                   (Coomassie-Blue-stained) 
  
 
 
 
4.3.7 Partial sequencing of the separated polypeptides  
 
 
 
The enzymatic digestion with trypsin and the subsequent partial sequencing of the resulting 
peptides by mass spectrometric analysis was carried out by Dr. Nimtz at the Gesellschaft für 
Biotechnologische Forschung (GBF) in Braunschweig. 
Mass spectrometry (MS) is an important and emerging method for the identification of gel-
separated proteins and makes use of the rapidly growing sequence databases. Generally, there 
are two MS methods that can be used to identify proteins: matrix-assisted laser desorption 
ionization - time of flight (MALDI-TOF) and tandem mass spectrometry (MS/MS). Both 
methods work best when trypsin digestion is used to break up each protein into multiple 
peptide fragments. 
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The four protein spots were excised from the Coomassie-Blue-stained 2-D gel and subjected 
to tryptic digestion to yield a mixture of peptide fragments. The larger peptide fragments were 
analysed by mass spectrometry using electrospray ionization tandem-MS (ESI-MS/MS). The 
resulting tryptic peptide sequence information served for database searching using the Fasta 
database search program Uniprot (http://www.ebi.ac.uk/fasta33/). The Fasta program can be 
very specific when identifying long regions of low similarity especially for highly diverged 
sequences. 
This search consistently detected significant homology between the larger peptide fragments 
and the elongation factor 2, but no homology was found with prenyltransferases and terpene 
synthases. Obviously, the major portion of the purified protein was elongation factor 2. An 
additional protein spot possibly containing the prenyltransferase was unfortunately not 
detectable in 2D-electrophoresis.   
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5.    Discussion 
 
 
Hyperforin is an important constituent of St. John’s wort preparations. While the 
pharmacological activities of this compound have intensely been studied, little is known about 
the biosynthesis of hyperforin. Recently, the formation of hyperforin and its homologue 
adhyperforin has been detected in H. calycinum cell suspension cultures (Klingauf et al., 
2005). Cell cultures of other Hypericum species (H. perforatum, H. androsaemum, H.  
gnidioides) failed to accumulate hyperforins. Thus, cell cultures of H. calycinum turned out to 
be a valuable in vitro system for studying the biosynthesis of hyperforins (Klingauf et al., 
2005). Contrary to intact H. perforatum plants which accumulate hyperforin, cell cultures of 
H. calycinum contain mainly the homologue adhyperforin. The antidepressant activity of 
adhyperforin resembles that of hyperforin ((Maisenbacher and Kovar, 1992; Jensen et al., 
2001). So far, hyperforins have not been detected in differentiated H. calycinum plants, 
although several dearomatized polyprenylated acylphloroglucinols have been isolated from 
this species (Decosterd et al., 1998; Gronquist et al., 2001). One of these constituents showed 
antimalarial activity in an in vitro test system (Decosterd et al., 1991). Where the lipophilic 
compounds accumulate in differentiated plants and cultured cells of Hypericum species is still 
open. In mice, alcoholic extracts from H. calycinum exhibited antidepressant activity which 
compared to that of extracts from H. perforatum (Öztürk, 1997). In the same study, H. 
hyssopifolium ssp. had no antidepressant activity.  
 
In flowers of H. calycinum, the ecological function of polyprenylated acylphloroglucinol and 
benzophenone derivatives has recently been studied (Gronquist et al., 2001). These 
compounds accumulate in those parts of petals which are exposed to the outside in the 
unopened bud. This is the first time that constituents other than flavonoids were found to 
serve as floral UV pigments. Interestingly, the polyprenylated compounds also accumulate to 
a high extent in anthers and the ovarian wall and provide protection against herbivores. Thus, 
they fulfill both attractive and defensive functions in H. calycinum flowers. 
 
The skeleton of hyperforin is the phloroglucinol derivative phlorisobutyrophenone, the 
formation of which is catalyzed by isobutyrophenone synthase (BUS). This enzyme catalyzes 
the sequential condensation of one molecule of isobutyryl-CoA with three molecules of 
malonyl-CoA to form the hyperforin nucleus (Klingauf et al., 2005; Fig. 5-1). An increase in 
BUS activity preceded the formation of hyperforins during cell culture growth.   
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Fig. 5-1: Reactions of three type III polyketide synthases from H. calycinum cell cultures 
 
 
That a polyketide mechanism underlies the formation of the hyperforin skeleton, was 
confirmed by a retrobiosynthetic NMR study (Adam et al., 2002). Cultured H. calycinum cells 
contained, besides BUS, chalcone synthase (CHS) and benzophenone synthase (BPS) 
activities. These enzymes were separated by anion exchange chromatography. While the 
preferential starter substrate of BPS is benzoyl-CoA, leading to the formation of 
phlorbenzophenone, CHS prefers 4-coumaroyl-CoA, resulting in the formation of naringenin 
chalcone. Both products can undergo intramolecular cyclization to give xanthones and 
flavonoids, respectively. BUS, BPS and CHS belong to the superfamily of type III polyketide 
synthases. These enzymes generate a diverse array of secondary metabolites by condensing 
multiple acetyl units derived from malonyl-CoA to specific starter molecules (Jez et al., 2002). 
The homodimeric enzymes orchestrate a series of acyltransferase, decarboxylation, 
condensation, cyclization, and aromatization reactions at two functionally independent active 
sites. 
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 The structure of the active site dictates starter substrate preference, polyketide chain-length, 
and regio-specificity of polyketide cyclization. These strategies have increased considerably 
the functional diversity of type III PKSs. 
 
In hyperforin biosynthesis, phlorisobutyrophenone undergoes a series of prenylation reactions. 
A proposed biosynthetic pathway (Adam et al., 2002) is depicted in Fig. 5-2. The 
unsubstituted acylphloroglucinol precursor requires a triple electrophilic substitution of the 
aromatic nucleus involving two DMAPP units and one geranyl pyrophosphate as well as a 
ring closure triggered by electrophilic attack of a third DMAPP unit. The sequence of these 
steps remains to a large extent unidentified. Mechanistic considerations require the cyclization 
to be preceded by quaternization of the carbon atom to which the geranyl chain is appended. 
Subsequent quaternization of a preformed bicyclic intermediate would involve the 
participation of an unduely strained bridgehead enolate ion. One of the remaining possibilities 
satisfying this restriction and substantiating an earlier suggestion (Bystrov et al., 1975) is 
illustrated in Fig. 5-2.  
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Fig. 5-2:  Hypothetical pathway of hyperforin biosynthesis 
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The five isoprenoid moieties which participate in hyperforin biosynthesis are derived 
predominantly (>98%) via the non-mevalonate pathway, as shown by a retrobiosynthetic 
NMR study (Adam et al., 2002). Involved are a series of enzyme-catalyzed reactions 
summarized in Fig. 5-3. The initial step of this route is the formation of 1-deoxy-D-xylulose 5-
phosphate 3 (DXP) by condensation of glyceraldehyde 3-phosphate 2 and (hydroxyethyl) 
thiamine resulting from the decarboxylation of pyruvate 1. This reaction is    catalyzed by the 
thiamine diphosphate-dependent DXP synthase (DXS). The second enzyme of this 
biosynthetic pathway, the DXP reductoisomerase (DXR), catalyzes the transformation of DXP 
into methylerythritol MEP 5. The third step is conversion of MEP 5 into 4-diphosphocytidyl-
2-C-methyl-D-erythritol 6 by the 4-diphosphocytidyl-2-C-methyl-D-erythritol-synthase. 
Subsequent phosphorylation of the C-2 hydroxyl group of 6 yields 7. 4-Diphosphocytidyl-2-
C-methyl-D-erythritol-2-phosphat 7 is converted by the 2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase to 2C-Methyl-D-erythritol-2,4-cyclodiphosphat  8. (E)-4-Hydroxy-
3-methylbut-2-enyl diphosphate 9 is a transient intermediate, directly derived from cMEPP 8, 
which is subsequently dehydroxylated to yield IPP/DMAPP (10/11). Thus, the deoxyxylulose 
phosphate pathway in higher plants appears to be completely elucidated at the level of 
intermediates. Recent studies have shown a wide variety of plant terpenoids to be formed by 
the non-mevalonate pathway (Dubey et al., 2003), such as isoprene from Chelidonium majus 
(Zeidler et al., 1997), thymol from Thymus vulgaris (Eisenreich et al., 1997), β-carotene from 
Liriodendron tulipifera (Sagner et al., 1998), cineole from Eucalyptus globulus (Rieder et al., 
2000) and borneol from Conocephalum conicum (Theil and Adam., 2002). The plastids have 
long been accepted as a major subcellular site of isoprenoid metabolism this finding is 
underscored by the recent discovery that these organelles possess a DXP pathway for the 
production of the universal isoprenoid precursor IPP (Eisenreich et al., 1998). In the case of 
prenylated aromatics, it has been reported that the dimethylallyl group of several aromatic 
compounds (Goese et al., 1999; Stanjek et al., 1999; Asada et al., 2000) and the geranyl group 
of cannabinoids (Fellermeier et al., 2001) are derived from the DXP pathway. Furthermore, 
prenylation of isoflavonoids in French bean (Phaseolus vulgaris) and soybean (Glycine max; 
Biggs et al., 1990) and of furanocoumarins in Ruta graveolens (Dhillon and Brown, 1976) 
occurrs in the plastids. In contrast, in cultured Lithospermum erythrorhizon cells, GPP 
supplied by the mevalonate pathway (Li et al., 1998) in the ER/cytosol (Sommer et al., 1995) 
was utilized for the prenylation of p-hydroxybenzoic acid, which was associated with the ER 
(Yamaga et al., 1993).  
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Fig. 5-3: Deoxyxylulose phosphate (non-mevalonate) pathway leading to the formation 
of isopentenyl diphosphate (10) and dimethylallyl diphosphate (11) 
 
 
The present work reports detection, characterization and partial purification of the 
dimethylallyltransferase that is responsible for the first prenylation step in hyperforin 
biosynthesis. The enzyme catalyses the conversion of phlorisobutyrophenone to 
dimethylallylphlorisobutyrophenone in the presence of DMAPP and Fe2+ (Fig. 5-4). The 
enzymatic product was unequivocally identified as dimethylallylphlorisobutyrophenone by 1H 
NMR and MS analyses.  
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Fig. 5-4:  Prenylation of the hyperforin nucleus by phlorisobutyrophenone 
                                                      dimethylallyltransferase 
 
Hyperforin accumulation between day 3 and 6 of cell culture growth was preceded by an 
increase in dimethylallyltransferase activity, strongly indicating that this enzyme is involved 
in hyperforin biosynthesis. Other pathways involving prenylation reactions in Hypericum 
species lead to the formation of polyprenylated benzophenone derivatives. Some previously 
characterized prenyltransferases are p-hydroxybenzoate polyprenyltransferase involved in 
ubiquinone biosynthesis (Thomas and Threlfall, 1973), homogentisate polyprenyltransferase 
participating in the biosynthesis of plastoquinone and tocopherol (Pennock, 1985; Marshall et 
al., 1985) and 1, 4-dihydroxynaphthoate polyprenyltransferase leading to phylloquinone 
formation (Schultz et al., 1981). 
 
Prenyltransferases catalyze the electrophilic alkylation of electron-rich acceptor substrates by 
the hydrocarbon moiety of allylic isoprenoid diphosphates (Poulter and Rilling, 1978; Poulter 
et al., 1979). Some of the more common acceptors are carbon-carbon double bonds (synthesis 
of isoprenoid chains; Szkopiñska, 2000), aromatic rings (e.g. synthesis of respiratory quinones 
and vitamins E; Ashby and Edwards, 1990), amino groups (e.g modification of tRNAs; 
Caillet and Droogmans, 1988) and sulfhydryl moieties (e.g modification of proteins such as 
ras-farnesyltransferase and anti-proliferation target; Stöber et al., 1997, Mayer et al., 1993). In 
these prenyl side chain conjugation reactions, the adequate length of the prenyl diphosphate 
which is biosynthesized before-hand by prenyl diphosphate elongation enzymes is thought to 
be directly transferred to the prenyl acceptor (Fellermeier and Zenk, 1998; Mühlenweg et al., 
1998; Liang et al., 2002). The products of prenyl transfer reactions are ultimately converted 
into over 30000 naturally occurring isoprenoid compounds and it is well known that many 
prenyl side chain-conjugated compounds have important biological functions, such as defence  
Discussion                                                                                                                                 85 
 
and attraction (Barron and Ibrahim, 1996). Isoprenoid biosynthesis is essential in all 
organisms. In Escherichia coli, for instance, the isoprenoids ubiquinone and bactoprenol are 
required for respiration and cell wall biosynthesis, respectively. The aromatic 
polyprenyltransferase encoded by ubiA is involved in the biosynthesis of prenylated quinones 
(Shineberg and Yong, 1976). The enzyme transfers diphosphorylated acyclic oligoprenyl 
moieties (diphosphorylated terpene alcohols) to the meta-position of 4-hydroxybenzoic acid 
(Wessjohann and Sontag, 1996;  Wessjohann  et al., 1999; Wessjohann and Sontag, 1998). 
Prenyltransferases also participate in the biosynthesis of flavonoids (Yamamoto et al., 2000), 
coumarins (Hamerski et al., 1990), cannabinoids (Fellermeier and Zenk, 1998), hop bitter  
acids (Zuurbier et al., 1998), and shikonin (Yazaki et al., 2002). The shikonin-related enzyme 
was the first prenyltransferase to be cloned from a plant source, namely cell cultures of 
Lithospermum erythrorhizon. The enzyme catalyzes the transfer of a geranyl residue to 4-
hydroxybenzoic acid. 
 
The dimethylallyltransferase which is responsible for the first prenylation step in hyperforin 
biosynthesis is a so-called aromatic prenyltransferase which catalyzes the formation of a 
carbon-carbon bond between an aromatic nucleus and a prenyl group. The majority of the 
aromatic prenyltransferases are integral membrane proteins (Dhillon and Brown, 1976; 
Schröder et al., 1979; Biggs et al., 1987; Hamerski et al., 1990; Welle and Grisebach, 1991; 
Laflamme et al., 1993; Yamamoto et al., 1997, 2000; Mühlenweg et al., 1998). Their catalytic 
centers include a typical prenyl disphophate binding site: (N/D)DXXD. Examples of this 
enzyme family are the prenyltransferases involved in the biosynthesis of the primary 
metabolites ubiquinone (Turunen et al., 2004), menaquinone (Suvarna et al., 1998), 
tocopherol (Schledz et al., 2001) and plastoquinone (Collakova and DellaPenna, 2001). The 
same binding motif is also present in the chain-elongating trans-prenyltransferases such as 
geranyl diphosphate synthase, farnesyl diphosphate synthase, and geranylgeranyl diphosphate 
synthase (Wang and Ohnuma, 1999; Bohlmann et al., 1998; Liang et al., 2002; Sacchettini 
and Poulter, 1997). The geranyltransferase cloned from L. erythrorhizon also belongs to this 
group (Yazaki et al., 2002).   
 
Another class of aromatic prenyltransferases includes soluble enzymes which are, in addition, 
active in a metal-free buffer containing EDTA. An example is dimethylallyltryptophan 
synthase (DMATS) which catalyzes the prenylation of tryptophane at position C-4 of the 
indole nucleus in ergot alkaloid biosynthesis in the fungus Claviceps purpurea (Cress et al., 
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1981; Lee et al., 1976; Tsai et al., 1995; Tudzynski et al., 1999). Further soluble 
prenyltransferases that use aromatic substrates and are active in the absence of metal ions and 
lack the (N/D)DXXD motif are CloQ which is involved in the biosynthesis of clorobiocin 
from Streptomyces roseochromogenes (Pojer et al., 2003), and LtxC which participates in the 
biosynthesis of lyngbyatoxins from Lyngbya majuscula (Edwards and Gerwick., 2004). Very 
recently, an orthologue of DMATS (FgaPT2) was identified in the genome sequence of 
Aspergillus fumigatus (Unsöld and Li, 2005). Interestingly, DMATS, CloQ and LtxC share no 
a ppreciable sequence similarity, despite their similar biochemical properties.   
 
The dimethylallyltransferase from cultured H. calycinum cells differs from the members of 
the above-mentioned classes of prenyltransferases in that it is soluble and its activity 
dependent on a divalent cation. It is the first plant prenyltransferase to prefer Fe2+. Other 
enzymes are most active with Mg2+ (Hamerski et al., 1990; Yamamoto et al., 1997; 
Fellermeier and Zenk, 1998; Mühlenweg et al., 1998; Yamamoto et al., 2000; Tholl et al., 
2001) or Mn2+ (Dhillon and Brown, 1976; Biggs et al., 1987; Welle and Grisebach, 1991; 
Laflamme et al., 1993). Purified dimethylallyl:tRNA dimethylallyltransferase from 
Escherichia coli which is involved in adenosine biosynthesis prefers Mn2+ and Fe2+ as 
cofactor (Bartz and Söll, 1972). In contrast, many protein prenyltransferases contain a tightly 
bound zinc atom (Harris et al., 2002). The dimethylallyltransferase from cultured H. 
calycinum cells exhibited with Zn2+ only 41% of the activity obtained in the presence of Fe2+. 
The maximum specific activity of this enzyme in crude extracts was 3.6 µkat /kg. This value 
is low, as compared to the activity of kaempferol 8-dimethylallyl transferase in Epimedium 
diphyllum cell cultures (23.3 µkat /kg; Yamamoto et al., 1997), prenyltansferase in hop bitter 
acids (38 µkat /kg; Zuurbier et al., 1998), and 4-hydroxybenzoic acid geranyltransferase from 
shikonin-producing L. erythrorhizon cell cultures (68.4 µkat /kg; Heide and Tabata, 1987).  In 
contrast to previously reported prenyltransferase reactions for which the optimum pH was 
around 7.5 (Dhillon and Brown, 1976; Schröder et al., 1979; Biggs et al., 1987; Hamerski and 
Matern, 1988; Welle and Grisebach, 1991; Laflamme et al., 1993; Fellermeier and Zenk, 1998; 
Mühlenweg et al., 1998; Tholl et al., 2001), the prenyltransferase from cultured H. calycinum 
cells showed a broad pH optimum from 6.5 to 9. A similarly broad pH range was observed 
with the prenyltransferase from Epimedium diphyllum cell cultures (Yamamoto et al., 1997). 
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Some prenyltransferases previously characterized are remarkably similar to the 
dimethylallyltransferase from cultured H. calycinum cells, i.e. they are soluble and require a 
divalent metal ion. These enzymes are involved in the biosynthesis of bitter acids in hop 
(Humulus lupulus; Zuurbier et al., 1998) and of cannabinoids in hemp (Cannabis sativa; 
Fellermeier and Zenk, 1998). In glandular hairs of hop cones, the enzyme activity catalyzes 
the stepwise prenylation of acylphloroglucinols to yield deoxyhumulone and 
deoxycohumulone which are the direct precursors of the hop bitter acids. In leaves of Indian 
hemp, the enzyme catalyzes the alkylation of olivetolic acid with GPP. It will be interesting to 
study the evolutionary relationship between these enzymes which include the 
dimethylallyltransferase from H. calycinum cell cultures and the members of the two other 
classes of prenyltransferases. 
 
The Km values of the H. calycinum enzyme for DMAPP and phlorisobutyrophenone were in 
the range of Michaelis constants found for other plant aromatic prenyltransferases (Yamamoto 
et al., 1997). Dimethylallyltransferase links a dimethylallyl group to phlorisobutyrophenone, 
with the maximum reaction rate being observed at 2 to 8 mM DMAPP. Higher concentrations 
inhibited the enzyme (Fig. 4-17), as previously found with the geranyltransferase in cell-free 
extracts from cultured Lithospermum erythrorhizon cells, which catalyzes the geranylation of 
4-hydroxybenzoic acid (Heide and Tabata, 1987). Welle and Grisebach (1991) revealed that 
dimethylallyl diphosphate:trihydroxypterocarpan dimethylallyltransferase from Glycine max 
was competitively inhibited by IPP. Inhibition of the H. calycinum enzyme is thought to be 
also due to IPP formation from DMAPP by IPP isomerase present in cell-free extracts. 
Conversely, product formation occurred in the presence of IPP, which was likewise attributed 
to IPP isomerase activity in crude extracts. Dimethylallyltransferase accepted only DMAPP as 
prenyl donor. Geranyl pyrophosphate, farnesyl pyrophosphate and geranylgeranyl 
pyrophosphate were not transferred to phlorisobutyrophenone (Table 4-2), indicating that the 
dimethylallyltransferase strictly recognizes the chain length of the prenyl donor. Similarly, 
dimethylallyltransferase showed high specificity for phlorisobutyrophenone which is the 
physiological acceptor, i.e. the acylphloroglucinol moiety of hyperforin. While the 
structurally closely related substrate phloracetophenone was also efficiently converted, 
phloroglucinol was not. 
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Recently, a new branch point in the biosynthesis of hyperforins was detected (Fig. 5-5; 
Charchoglyan et al., 2006). Shoot cultures of  H. perforatum were found to contain hyperforin 
and three related polyprenylated acylphloroglucinol derivatives. The accumulation of these 
compounds was coupled to shoot regeneration, with secohyperforin being the prominent 
constituent in morphogenic cultures. In multiple shoot cultures, the ratio of hyperforin to 
secohyperforin was strongly influenced by the phytohormones N6- benzylaminopurine (BAP) 
and naphthalene-1-acetic acid (NAA). While increasing concentrations of BAP stimulated the 
formation of hyperforin, increasing concentrations of NAA elevated the level of 
secohyperforin. Hyperforin and secohyperforin are likely to result from a branch point in the 
biosynthetic pathway. The diprenylated acylphloroglucinol intermediate is proposed to be 
linked to either a dimethylallyl or a geranyl residue. Metabolic channeling at the branch point 
might be due to differentially regulated prenyltransferases exhibiting specificity for DMAPP 
or GPP.  
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Fig. 5-5: Proposed branch point in the biosynthetic pathway of hyperforins 
 
Hypericum species contain, besides prenylated acylphloroglucinols such as hyperforin, 
polyprenylated benzophenone derivatives (Fig. 5-6). The skeleton of these constituents is 
formed by BPS catalyzing the iterative condensation of benzoyl-CoA with three molecules of 
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malonyl-CoA to give phlorbenzophenone. In H. androsaemum cell cultures, 3'-hydroxylation 
of this intermediate to yield 2,3',4,6-tetrahydroxybenzophenone is catalyzed by a cytochrome 
P450 monooxygenase (Schmidt and Beerhues, 1997). In cultured Centaurium erythraea cells, 
BPS prefers 3-hydroxybenzoyl-CoA as starter substrate, giving immediately the 
tetrahydroxylated metabolite (Beerhues, 996). 3-Hydroxybenzoate: CoA ligase was separated 
from 4-coumarate: CoA ligase and purified to homogeneity (Barillas and Beerhues., 2000). 
Simple benzophenones can undergo stepwise prenylation and cyclization reactions to give 
bridged polycyclic compounds such as sampsoniones and garcinols. Some of these complex 
molecules with caged skeletons exhibit interesting pharmacological properties, e.g. cytotoxic, 
antibacterial, and HIV-inhibitory activities (Balasubramanyam et al., 2004; Hu and Sim., 
1999; Matsumoto et al., 2003). Their mechanisms of action and target structures are under 
study. 
 
 
                     Fig. 5-6:  Polyprenylated benzophenone and xanthone derivatives 
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2,3',4,6-Tetrahydroxybenzophenone is also the precursor of xanthone biosynthesis (Fig. 5-6). 
It undergoes regioselective oxidative phenol coupling reactions which occur either ortho or 
para to the 3'-hydroxy group and yield 1,3,5- and 1,3,7-trihydroxyxanthones, respectively 
(Peters et al., 1998). These intramolecular   cyclizations   are catalyzed by  cytochrome  P450  
enzymes. The two isomeric products are the precursors of the majority of plant xanthones. 
This class of secondary metabolites likewise includes prenylated molecules with high 
pharmaceutical potential. Pronounced activity against methicillin-resistant strains of 
Staphylococcus aureus was observed with rubraxanthone, the efficiency of which was 
comparable to that of the antibiotic vancomycin (Iinuma et al., 1996). An example of a 
bridged polycyclic xanthone is gambogic acid which induces apoptosis independent of cell 
cycle by a novel mechanism of caspase activation (Zhang et al., 2004).    
 
Since most aromatic prenyltransferases are membrane-bound, their purification is difficult. 
Little progress towards solubilization and purification of plant prenyltransferases was 
described. Successful solubilization procedures were reported for the isoflavonoid 
prenyltransferase in soybean (Welle and Grisebach, 1991) and a peripheral membrane protein 
of rutacridone biosynthesis in Ruta graveolens cell cultures (Maier et al., 1993). Partial 
purification was achieved with the 4-hydroxybenzoate geranyltransferase from L. 
erythrorhizon (Mühlenweg et al., 1998). In contract, the dimethylallyltransferase from H. 
calycinum cell cultures is a soluble enzyme as has been shown in Tab. 4-3. This provides a 
good basis for a successful purification strategy. However, the activity of the 
dimethylallyltransferase was comparatively low and it could not be increased by elicitor 
treatment (Klingauf et al., 2005). A purification scheme for this enzyme utilizing differential 
anionic, hydrophobic, adsorptive and size properties of proteins was established. Hydrophobic 
interaction chromatography turned out to be an efficient purification step because a large 
portion of foreign protein was removed, leading to a considerable increase in the purification 
factor. Dimethylallyltransferase was eluted from the HIC column at high concentrations of 
ammonium sulphate, suggesting that the enzyme does not belong to the hydrophobic proteins.  
 
The purification scheme, as outlined in Fig. 4-34, led to a considerable increase in 
prenyltransferase purity (Tab. 4-4) and finally allowed association of protein bands in SDS–
PAGE with dimethylallyltransferase activity. In order to obtain a highly purified 
dimethylallyltransferase preparation, only fractions exhibiting high enzyme activity were 
pooled and subjected to the next purification step. This, however, resulted in a relatively low 
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recovery (0.29%) and a poor purification factor (65). Previously, a low yield was also 
observed with the purified 4-hydroxybenzoate geranyltransferase from L. erythrorhizon cell 
cultures (Mühlenweg et al., 1998). Prenyltransferases, in addition, appear to be relatively 
unstable proteins during the purification procedure. The six step-purification process provided 
an apparently homogeneous preparation of dimethylallyltransferase protein, as determined by 
sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Two closely-
migrating protein bands with molecular masses of about 31 and 31.5 kDa were detected. The 
native molecular mass of the prenyltransferase, as estimated by gel-filtration chromatography, 
was about 63 kDa. These results suggested that the purified enzyme was active as a 
heterodimer. A prenyltransferase from the fungus Aspergillus fumigatus, encoded by the gene 
fgaPT1, has recently also been found to be active as a dimer (Unsöld and Li, 2006). 
 
The final separation was achieved by two-dimensional gel electrophoresis, leading to the 
detection of four spots. These polypeptides were amenable to identification by in-gel trypsin 
digestion, followed by ESI–MS/MS sequence analysis of the resulting tryptic peptides. So far, 
only few sequences for "aromatic" prenyltransferases from plants are available. Unfortunately, 
none of the tryptic peptides exhibited amino acid sequence similarity to known 
prenyltransferases and terpene synthases. In contrast, all four polypeptides separated by 2D 
electrophoresis turned out to be isoforms of the elongation factor 2. Elongation factors of 
protein synthesis constitute one of the major families of cellular GTP-binding proteins, also 
called GTPases. Members of the GTPase superfamily are characterized by conserved 
structural motifs and their ability to alternate between specific conformations by binding 
either GTP or GDP. The alternate conformations associated with the binding and hydrolysis 
of GTP allows the GTPases to function as “molecular switches” in the specific activation of 
other cellular components. In the elongation phase of protein synthesis, the translocation of 
the ribosome along the messenger RNA requires an elongation factor (EF-G in prokaryotes 
and EF-2 in eukaryotes) and is accompanied by the hydrolysis of GTP. It is presumed that the 
translocation process is driven by a change in the conformation of the EF-2 GTP-binding 
domain associated with GTP hydrolysis. 
 
In conclusion, the purification procedure that was established in this work turned out to be in 
principal suitable for the isolation of the soluble prenyltransferase from H. calycinum cell 
cultures. Enzyme activity could be profiled during the six-step procedure. In the future, the 
individual chromatographic steps will be further improved and the amount of cell-free extract 
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as starting material will be increased. This strategy will hopefully provide purified 
dimethylallyltransferase protein, from which partial sequences can be derived as a basis for 
subsequent cDNA cloning. 
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6.     SUMMARY 
 
 
 St. John's wort (Hypericum perforatum L., Clusiaceae) has been used as a medicinal herb 
for over 2000 years. Application of its extracts for treating depression has undergone 
rigorous scientific investigation. The major antidepressant constituent appears to be 
hyperforin. This polyprenylated phloroglucinol derivative exhibits a broad-band inhibitory 
effect on the neuronal reuptake of serotonin, noradrenaline, dopamine, gamma-aminobutyric 
acid (GABA), and L-glutamate. It is both a structurally and functionally new antidepressant. 
 
 The enzyme which catalyzes the first prenylation step in hyperforin biosynthesis was 
detected in cell cultures of H. calycinum grown in BDS medium in the dark. Thus, these cell 
cultures turned out to be a valuable in vitro system for studying hyperforin biosynthesis. 
 
 Dimethylallyl diphosphate (DMAPP) was chemically synthesized as a donor substrate. It 
was incubated with cell-free extracts from H. calycinum cell cultures in the presence of a 
divalent cation and phlorisobutyrophenone as the acceptor substrate. These enzyme assays 
resulted in the formation of dimethylallylphlorisobutyrophenone, as identified by HPLC and 
GC-MS in comparison with a chemically synthesized reference compound.  
 
 The responsible enzyme showed a broad pH optimum from 6.5 to 9 and a temperature 
optimum at 38oC. The enzyme reaction was linear with time up to 30 min and with the 
protein amount up to 80 µg in the assay. 
 
 Dimethylallyltransferase activity was strictly dependent on a divalent cation, with Fe2+ 
being the most efficient cofactor. Lower activities were observed with Mg2+, Zn2+, and Cu2+. 
The optimum ferrous concentration was 10 mM. The preference for ferrous was not due to 
its reducing properties because experiments in the presence and the absence of 10 mM 
ascorbic acid gave the same result. 
 
 The transferase used DMAPP as prenyl donor. Product formation also occurred in the 
presence of IPP, which, however, was attributed to IPP isomerase activity in the crude 
extract. No enzyme activity was observed with GPP, FPP, and GGPP as prenyl donors. The 
preferred prenyl acceptor was phlorisobutyrophenone. High transferase activity was also 
found with phloracetophenone. The product resulting from this acceptor substrate was 
identified as dimethylallylphloracetophenone in comparison with an authentic sample that 
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was chemically synthesized. No enzyme activity was found with phloroglucinol as prenyl 
acceptor. 
 
 Kinetic parameters were determined from Lineweaver-Burk plots. The Km values were 
0.46 mM for DMAPP, 0.52 mM for phlorisobutyrophenone, and 3.8 mM for  Fe2+.  
 
 After ultracentrifugation, the majority of enzyme activity (80 %) was found in the 
supernatant, indicating that the dimethylallyltransferase involved in hyperforin biosynthesis 
was a soluble enzyme.  
 
 The accumulation of hyperforins in H. calycinum cell cultures occurred between day 3 
and 6 and was preceded by an increase in dimethylallyltransferase activity. The maximum 
specific enzyme activity was 3.6 µkat/kg protein.   
 
 The dimethylallyltransferase was purified using ammonium sulphate precipitation, 
followed by five column chromatographic steps including DEAE and Mono-Q anion 
exchange chromatography, hydroxylapatite adsorption chromatography, hydrophobic 
interaction chromatography and gel filtration.     
 
 On a calibrated gel filtration column, the relative molecular mass (Mr) of the 
dimethylallyltransferase was 63 000. In SDS-PAGE, the purified protein gave two closely 
spaced polypeptide bands with Mr 31 000 and 31 500, suggesting that the enzyme was 
active as a heterodimer.  
 
 The purified protein was subjected to two-dimensional electrophoresis, giving four protein 
spots. Tryptic digestion of the individual polypeptides and sequence analysis of the resulting 
peptides by ESI-MS/MS revealed that all four polypeptides were isoforms of the elongation 
factor 2. No sequence similarity was observed with prenyltransferases. 
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A) Chemical synthesis of the reference dimethylallylphlorisobutyrophenone 
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B)  Acetylation of the reference dimethylallylphlorisobutyrophenone 
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                                                                                                    C21H26O7 
                                                                                             Exact Mass: 390.04 
 
 
Mass spectrum of 1- methylpropanoyl-3-[3',3'-dimethylallyl-(1')]-2,4,6-tri-O-acetyl-
phloroglucinol:                                                                                                                                 
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C)  Silylation of the reference dimethylallylphlorisobutyrophenone 
 
 
                                                                                               
 
 
 
 
 
                                       
                                                          80 ºC, 30 min 
                          
 
 
 
                                                                                                   C24H44O4 Si 3 
                                                                                             Exact Mass: 480,68 
 
 
 
Mass spectrum of 2-methyl-1-[3-(3-methyl-but-2-enyl)-2,4,6-tris-trimethylsilanyloxy-
phenyl]-propan-1-one: 
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D) Chemical synthesis of the reference dimethylallylphloracetophenone 
 
 
 
 
Mass spectrum of 3-(3-methyl-2-butenyl)-2,4,6-trihydroxyacetophenone: 
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C13H16O4
Exact Mass: 236,10
1. KOH, 0 °C
2. HCl, Et2O
+
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E)  Acetylation of the reference dimethylallylphloracetophenone 
 
        
 
 
                                                             RT, 20 hrs 
 
 
 
 
 
 
 
 
 
 
Mass spectrum of 1-acetyl-3-[3',3'-dimethylallyl-(1')]-2,4,6-tri-O-acetyl-phloroglucinol: 
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F)  Silylation of the reference dimethylallylphloracetophenone 
 
 
                                                                               
 
 
 
 
 
 
                                                        80 ºC, 30 min 
 
 
 
 
                                                                                      
                                                                                          C22H40O4 Si3 
                                                                                                                                  
Exact Mass: 452.64 
 
 
 
 
 
Mass spectrum of 1-[3-(3-methyl-but-2-enyl)-2,4,6-tris-trimethylsilanyloxy-phenyl]-
ethanone: 
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